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ABSTRACT OF THE DISSERTATION
DEVELOPMENT OF GAUSSIAN LEARNING ALGORITHMS FOR EARLY
DETECTION OF ALZHEIMER’S DISEASE
by
Chen Fang
Florida International University, 2020
Miami, Florida
Professor Malek Adjouadi, Major Professor
Alzheimer’s disease (AD) is the most common form of dementia affecting 10% of the
population over the age of 65 and the growing costs in managing AD are estimated to be
$259 billion, according to data reported in the 2017 by the Alzheimer's Association.
Moreover, with cognitive decline, daily life of the affected persons and their families are
severely impacted. Taking advantage of the diagnosis of AD and its prodromal stage of
mild cognitive impairment (MCI), an early treatment may help patients preserve the quality
of life and slow the progression of the disease, even though the underlying disease cannot
be reversed or stopped. This research aims to develop Gaussian learning algorithms, natural
language processing (NLP) techniques, and mathematical models to effectively delineate
the MCI participants from the cognitively normal (CN) group, and identify the most
significant brain regions and patterns of changes associated with the progression of AD.
The focus will be placed on the earliest manifestations of the disease (early MCI or EMCI)
to plan for effective curative/therapeutic interventions and protocols.
Multiple modalities of biomarkers have been found to be significantly sensitive in
assessing the progression of AD. In this work, several novel multimodal classification

vii

frameworks based on proposed Gaussian Learning algorithms are created and applied to
neuroimaging data. Classification based on the combination of structural magnetic
resonance imaging (MRI), positron emission tomography (PET), and cerebrospinal fluid
(CSF) biomarkers is seen as the most reliable approach for high-accuracy classification.
Additionally, changes in linguistic complexity may provide complementary
information for the diagnosis and prognosis of AD. For this research endeavor, an NLPoriented neuropsychological assessment is developed to automatically analyze the
distinguishing characteristics of text data in MCI group versus those in CN group. Early
findings suggest significant linguistic differences between CN and MCI subjects in terms
of word usage, vocabulary, recall, fragmented sentences.
In summary, the results obtained indicate a high potential of the neuroimagingbased classification and NLP-oriented assessment to be utilized as a practically computer
aided diagnosis system for classification and prediction of AD and its prodromal stages.
Future work will ultimately focus on early signs of AD that could help in the planning of
curative and therapeutic intervention to slow the progression of the disease.
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CHAPTER I.

INTRODUCTION

According to the National Institute on Aging (NIA), before memory loss and other
cognitive impairments can be observed as evidence for Alzheimer's Disease (AD), subtle
changes to the brain have already started for a decade or more, and moreover, Alzheimer’s
disease (AD) may be estimated as the third leading cause of death for the older population
in the United States, just behind heart disease and cancer [1]. Although there still is no
known cure for the disease, alleviation of specific symptoms is possible through treatment
for some patients in the early or middle stages of AD. Thus, accurate diagnosis of its
prodromal stage, mild cognitive impairment (MCI), with a high risk to convert to AD, is
essentially important as means to facilitate planning for early intervention and treatment
[2]. Multiple modalities of biomarkers have been found to be significantly sensitive in
assessing the progression of AD. These include structural magnetic resonance imaging
(MRI) [3-11], positron emission tomography (PET) [5, 6, 10, 12-14], cerebrospinal fluid
(CSF)

[6,

13-15],

electroencephalographic

(EEG)

rhythms

[16-29],

and

Magnetoencephalography (MEG) [30, 31]. Using these modalities of biomarkers and
taking advantage of advances made in the development of machine learning and deep
learning algorithms over the past few years, several approaches have been proposed to
assist in the early diagnosis of MCI [8-10, 12-14, 32-34]. Since no matter which modality
or modalities of biomarkers are used, there will always be multiple variables for predicting
the progression of the disease, which ultimately can be generalized as a high-dimensional
classification problem.
Currently, many machine learning and deep learning algorithms capable of dealing
with high-dimensional data have been applied to classification and regression analysis in
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the context of disease diagnosis and transition predictions. The more notable of these types
of algorithms are Random Forest (RF), Support Vector Machines (SVM), Sparse
Representation-based classification (SRC), and Deep Belief Networks (DBN) [3, 8-10, 1214, 32-34]. Among these state-of-the-art algorithms, SVM continues to be one of the most
widely used for the classification of AD and its prodromal stages. But SVM still faces
serious challenges, especially in the selection of the kernel function parameters for
nonlinear problems, even under the so-called kernel trick, which remain essentially
difficult to overcome, view of the high variance in the main features that define the disease.
In particular, for discriminating MCI from elderly cognitively normal control group (CN),
the classification performance of SVM remains insufficient, ranging between 79% and
83% in accuracy, and the sensitivity is substantially lower than that for AD vs. CN (the
easiest two groups to separate) and even not significantly better than chance [3, 9, 10, 32].
Although many of the state-of-the-art strategies and techniques continue to advance our
understanding of AD, there remain many challenges in the different experimental stages at
determining more conclusive evidence for the accurate diagnosis and classification of AD,
as expressed in studies [33, 34].
As a way to overcome such challenges, this study first develops a series of machine
learning classification algorithm based on the Gaussian discriminant analysis (GDA),
introducing the use of dual decisional spaces, one for each hemisphere. Among those
modalities, structural MRI is currently widely used for analyzing the gradual progression
of atrophy patterns in key brain regions [35], therefore, this study makes use of structural
MRI as the unique input. To the best of our knowledge, this study is the first to apply GDA
to the diagnosis of CN vs. MCI, with the CN vs. AD classification results included here
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only for comparative purposes. The feature selection results of these proposed methods
demonstrate that the entorhinal cortex is the most significant cortical region for
distinguishing CN from MCI and more evidently for AD, which is consistent with recent
studies concluding that the entorhinal cortex, deep in the brain, is the first area to be
implicated in AD [36-38].
In recent years, machine learning approaches have been applied in a growing
number of studies to characterize patterns of structural, functional and metabolic difference
discernible from multimodal neuroimaging data. The high-dimensionality nature of
neuroimaging data often raises a necessity for dimensionality reduction and feature
selection to obtain an optimal decision space. The results reported in some recent studies
indicate that appropriate decision-making methods could improve the classification
accuracy regardless of the sample size [39-42]. Voxel-based MRI studies have
demonstrated that widely distributed cortical and subcortical brain regions show atrophy
patterns in MCI, preceding the onset of AD [43-47]. A recent study has indicated the
clinical utility of PET imaging for differential diagnosis in early onset dementia in support
of clinical diagnosis of participants with AD and noncarrier APOE ε4 status who are older
than 70 years [48]. Empirical evidence suggests that appropriate feature selection could
preserve the complementary inter-modality information; therefore, the proposed
dimensionality reduction model shows great potential for extracting relevant information
from all modalities associated with the progression of AD.
Currently, the Principal Component Analysis (PCA) model remains the most
widely used method in dimensionality reduction and feature selection tasks [49, 50].
However, for machine learning tasks like classification and regression analyses, PCA is
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applied as an unsupervised method not considering the interclass information, such as data
labels and target values; therefore, in many cases the consequently implemented feature
selection methods may not be able to find the optimal decision spaces for the corresponding
tasks. Moreover, the importance of PCA generated components is estimated by the
variance, which are not often equivalent to the significance of those components in
machine learning tasks.
This study also aims to introduce a supervised dimensionality reduction algorithm
to characterize the important Gaussian discriminative components with respect to the
structural, functional or metabolic measurements as observed in the MRI-PET combination
associated with different stages of AD, focusing on the prodromal stage of MCI [51, 52].
The stage of MCI is subdivided into two stages, early MCI (EMCI) and late MCI (LMCI),
as defined in the Alzheimer’s disease Neuroimaging Initiative (ADNI) data. Since
alleviation of specific symptoms is possible through therapeutic interventions for some
patients in the early or middle stages of AD, effective diagnosis of EMCI from CN group
is essentially important for the planning of early treatment. However, instead of utilizing
PCA computed variances to determine the significances of different components, the
proposed Gaussian discriminative component analysis (GDCA) makes use of GDA
classifiers to reveal the discriminability of different components in terms of each
component’s performance obtained by a designate machine learning task. This process is
shown to lead to stable, reliable and accurate dimensionality reduction in multimodal
neuroimaging biomarkers for effective classification, enhanced diagnosis and the
monitoring of disease progression.

4

Additionally, in order to yield more effective and accurate results, typically,
neuropsychological tests are used to screen patients for the discrimination of different
stages of AD, for example, the Mini-Mental State Examination (MMSE). Furthermore, the
1980s have seen the development of computerized neuropsychological testing systems that
have contributed substantially in assessing cognitive function and memory decline in
elderly patients in the early stages of Alzheimer’s disease [53-59]. In these thorough
reviews and studies, the general consensus is that although the psychometric measurements
were beneficial in assessing memory decline and could actually augment well-known and
common neuropsychological tests such as MMSE, the psychometric properties and
measurements varied from one test to another, and that each battery of tests could be judged
only on a case by case basis and on the type of application that is under consideration. This
suggests the need for the development of a more generalized application that takes into
consideration how well-conceived and easy to understand is the test.
As a well-known early symptom, some linguistic complexity changes of language
have been associated with the progression of MCI, for instance, forgetting some frequently
used terms [60]. Language troubles, occurred with executive function and memory
troubles, are the first clinical cognitive signs of AD. Although the language performance
depends on the education, age and some other factors for a given subject, word finding
difficulties and semantic paraphasia are still the most obvious symptoms among early AD
or MCI patients. During the early stage, affected by amnesic troubles, patients keep their
language capacity almost intact. Tests of language capacity (spoken and written,
production and perception) are usually performed during dedicated interviews. The most
frequent tests are related to oral expression (chat on a given topic, description of pictures,
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etc.) and the assessment of lexical production (naming of pictures, fluency, etc.), which
allow performing qualitative and quantitative assessment of language capacity in
controlled situations [53]. But, currently, the investigations of linguistic manifestations of
AD are mostly relied on manual analysis, while as one of the language use characteristics
sensitive to the effects of AD, linguistic complexity-based neuropsychological test cannot
be easily and effectively operated and measured using manual approaches [61]. Hence, it
is essentially important to build computerized neuropsychological tests that can
automatically implement the linguistic analysis and be more widely used in the diagnosis
of MCI.
The last part of this study aims at developing a natural language processing (NLP)oriented computerized neuropsychological assessment taking advantage of the existing
NLP techniques to find significant patterns of changes in linguistic complexity associated
with the progression of AD. By applying NLP techniques, it is possible to precisely
diagnose MCI based on the analysis of some conversation contents, such as, spoken
features, lexical features and syntactic features [62]. Some case studies have indicated that
the NLP technic is able to find clear patterns of decline in syntactic and grammatical
complexity [60, 61]. The proposed system will extract key features from discourse
transcripts, and evaluate on non-scripted news conferences from President Ronald Reagan
(RR), who was diagnosed with AD in 1994, and some other presidents, who have no known
diagnosis of AD, then indicate that over time, the patterns of the linguistic complexity
changes are statistically significantly distinguishable between RR and CN people.
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CHAPTER II.

A GAUSSIAN DISCRIMINANT ANALYSIS-BASED GENERATIVE

LEARNING ALGORITHM FOR THE EARLY DIAGNOISIS OF MILD COGNITIVE
IMPAIRMENT IN ALZHEIMER’S DISEASE
2.1. Goal
This chapter aims to introduce a novel generative learning algorithm based on the
GDA, which can achieve more effective and accurate classification performance than
SVM. To the best of our knowledge, this study is the first that applies GDA to the
classification of AD and MCI, with a focus placed on the classification of MCI vs. CN.
The feature extraction in this study demonstrates that the entorhinal cortex is the most
significant cortical region for distinguishing CN from MCI and more evidently for AD,
which is consistent with recent studies concluding that the entorhinal cortex, deep in the
brain, is the first area to be implicated in AD [36-38].
2.2. Methodology
In this section, the GDA-based generative algorithm is presented for the
classification of AD and MCI. First, several software pipelines are used to pre-process
original MRI data. Second, after the pre-processing step, morphometric (shape) data could
be derived from the images, including shape measures of all 25 labeled cortical regions.
Then a noise detection procedure and a feature extraction method based on the analysis of
variance (ANOVA) are employed to determine the statistical significance of each variable
in the classification outcome. Third, a GDA-based classifier is proposed for solving the
boundaries between any two different groups of subjects (i.e., CN vs. MCI, CN vs. AD,
and MCI vs. AD). The general framework of the proposed algorithm is presented in Fig.
1.
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Fig.1. General Framework of the GDA-based Algorithm.

8

Table 1.
Patient
Grou
Number
p
s
CN
190
MCI 305
AD
133
Total 628

Summary Statistics of Subjects
Mean  SD

MMSE

Age

Years of Edu.

Male
%

Female
%

29.1  1.0
27.0  1.8
23.5  1.9
26.9  2.6

75.9  5.1
74.9  7.1
74.8  7.6
75.2  6.7

16.1  2.7
15.7  3.0
14.7  3.1
15.6  3.0

51.6
64.9
51.1
58.0

48.4
35.1
48.9
42.0

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease,
MMSE: Mini–Mental State Examination, SD: standard deviation

2.2.1. Subjects
The data used in the preparation of this study were obtained from the ADNI database,
as part of the ADNI1: Complete 1Yr 1.5T collection and their assessments at baseline,
which includes 628 individuals (190 CN, 305 MCI, and 133 AD). The primary phenotype
is diagnostic group and MMSE. All source imaging data consist of 1.5 Tesla T1-weighted
MRI volumes in the NIfTI (.nii.gz) format from the ADNI1: Complete 1Yr 1.5T Data
Collection. Summary statistics and patient counts are listed in Table 1.
2.2.2. MRI Data Pre-processing
Using three neuroimaging software pipelines: FreeSurfer [63], Advanced
Normalization Tools (ANTs) [64], and Mindboggle [65], the original MRI data were preprocessed following the instruction provided by Alzheimer's Disease Big Data DREAM
Challenge #1 [66]. Tables of morphometric data were derived from the images using the
following seven shape measures for all 25 FreeSurfer labeled cortical regions for both left
and right hemispheres of the brain: 1) surface area; 2) travel depth; 3) geodesic depth; 4)
mean curvature; 5) convexity; 6) thickness; 7) volume. FreeSurfer pipeline (version 5.3)
was applied to all T1-weighted images to generate labeled cortical surfaces, and labeled
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cortical and noncortical volumes. Templates and atlases used by ANTs and Mindboggle
could be found on the Mindboggle website [67].
2.2.3. Noise Detection
The aforementioned pre-processed MRI data of the 25 labeled cortical regions were
used to generate two 175-variable (7  25) vector discriminator, for each subject (one 175variable vector per hemisphere). This study reveals that separating the variables for each
hemisphere of the brain yields a better classification performance than processing all
features together, with details in support of this assertion can be found in Section 2.4. As
for subjects which involved abnormal variables, for example, some regions having
measurements of some areas to be zero, these subjects should be regarded as noises and be
deleted from the dataset for further investigation.
2.2.4. Feature Selection
By the final stage of AD, brain tissue has atrophied significantly, so all shape
measures mentioned above could have changed as well. Some of the subtle changes
initially appear to take place in some specific areas of the brain, so determination of the
key changed regions of interest (ROIs) can help to discriminate more specifically MCI
from CN. The ANOVA was carried out on each of the 175 variables of the two vectors
between any two groups (i.e., CN vs. MCI, CN vs. AD, and MCI vs. AD) to determine the
significance of each variable in terms of classification outcome and all variables were
thereafter ranked according to their p-values. It should be noted that in the feature selection
procedure, equal weights were assigned to each of the shape measures so as to eliminate
any bias.
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2.2.5. Incremental Error Analysis
In order to maintain only few but key variables and still ensure good classification
performance, an incremental error analysis was performed to determine how many of the
top-ranked variables ought to be included in the classifier [2]. In the initial phase, the
proposed GDA-based classifier only used the first-ranked variable. The error analysis was
employed whereby introducing the next top-ranked variable in the classifier at each
subsequent phase, and recording the corresponding classification statistics, which then
would be compared with the previous phase. Until the performance cannot be improved
significantly anymore, the optimal set of variables would have been obtained.
2.2.6. GDA-based Classifier
Since there may be as many as 175 variables to be taken into consideration, the
classifier must be capable of dealing with a high dimensional classification problem. For
this reason, and by using GDA, an important generative learning algorithm for such
classification problems, the proposed classifier is able to solve the boundaries between any
two groups (i.e., CN vs. MCI, CN vs. AD, and MCI vs. AD). The classifier was applied to
each hemisphere of the brain (i.e., the two n-dimensional vectors), and if either one of the
two sides was classified to be positive, the corresponding subject should be positive as
well.
2.2.7. Classification Experiments
The performance of the proposed classifier was measured by using the accuracy,
sensitivity, specificity, positive predictive value, and negative predictive value based on
tenfold cross validation process. For selecting the optimal set of variables, 75% of the noise
detected subject data points were used in the tenfold cross validation process. After the

11

optimal set of variables was generated, the classification performance was evaluated by
using the remaining 25% of the noise detected subject data points.
2.3. Results
In this section, the experimental results of the feature selection process reveal the
significance of different ROIs in patients for the three classifications: 1) CN vs. MCI; 2)
CN vs. AD; 3) MCI vs. AD. The statistics evolution during the incremental error analysis
and the classification performance of the proposed GDA-based classifier are also
presented.
2.3.1. Top-ranked Variables
After the noise detection process, 9 subjects were removed because of the noisy
data which included measurements with zero values, so the final data used in the
classification experiment included 619 individuals, among them 187 CN, 301 MCI, and
131 AD. As mentioned earlier, ANOVA was performed for CN vs. MCI, CN vs. AD, and
MCI vs. AD using two 175-variable vectors corresponding to the left and right hemispheres
of the brain. For each group, all variables found at 0.01 level of significance (LOS) out of
all 175 variables for each side of the brain were used for the classification as shown in
Table 2.

Table 2.
Groups
Side of
brain

Number of Significant Variables
Selected for Each Comparison
CN vs. MCI CN vs. AD MCI vs. AD
Number of significant variables
(p-value < 0.01)

Left
Right

50
44

79
68

51
41

CN: cognitively normal control, MCI: mild cognitive impairment, AD:
Alzheimer’s disease
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Table 3.
Groups
Side
of
Rank
brain

Left

CN vs. MCI
Measurements

CN vs. AD
pvalue

Measurements

MCI vs. AD
pvalue

1

Thickness of entorhinal < 10-17 Thickness of entorhinal < 10-36

2

Curvature of entorhinal < 10-13 Curvature of entorhinal < 10-26
Thickness of middle
Thickness of middle
< 10-12 temporal
< 10-24
temporal

3

Right

Top-3 Significant Variables for Each Comparison

1

Thickness of entorhinal < 10-13 Thickness of entorhinal < 10-31

2

Thickness of middle
temporal

< 10-10 temporal

3

Thickness of fusiform

< 10-10 temporal

Measurements
Thickness of inferior
parietal
Thickness of entorhinal
Thickness of middle
temporal
Curvature of middle
temporal

pvalue
< 10-8
< 10-7
< 10-6
< 10-8

Thickness of middle

< 10-25 Thickness of entorhinal < 10-8

Curvature of middle

< 10-22 temporal

Thickness of middle

< 10-7

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease

The top 3 ranked variables and their corresponding measurements are given in
Table 3. From this table, it can be observed that the entorhinal cortex is the most significant
cortical region for discriminating either MCI or AD from CN. Even though for
distinguishing MCI from AD, it is the second top-ranked region. This observation is
consistent with recent studies indicating that indeed the entorhinal cortex is the first area
to be implicated in AD [36-38], which comes in support of the validity of our feature
selection method. Moreover, the entorhinal cortex has been proven as a major source of
projections to the hippocampus [68], which plays an important role in converting shortterm memory (also known as working memory) to long-term memory.
2.3.2. Optimal Sets of Variables
For the tenfold cross validation to generate the optimal set of variables, the
aforementioned 75% of the noise detected data points included 470 individuals (140 CN,
230 MCI, and 100 AD, all divisible by 10 for the tenfold cross validation) of the noise free
subjects included in this study (619 = 187 CN + 301 MCI + 131 AD). The purpose of
applying the incremental error analysis is to achieve the best classification performance
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(a)

(b)

(c)
Fig. 2.
Incremental Error Analysis Performance of Classification Statistics: (a) CN vs. MCI, (b) CN vs.
AD, and (c) MCI. vs. AD.

with the minimum number of variables (i.e., the number of dimensions in the decision
spaces). Some classification statistics of each hemisphere are illustrated in Fig. 2, where
the horizontal axis indicates the number of significant variables included in each iteration.
It should be noted that as a clinical application, the classification performance was
not only measured by the accuracy, which actually relies more on the sensitivity and
specificity. For selecting the optimal set of variables, the set with the highest sensitivity
was selected, when several sets had the same sensitivity value, the one with the highest
specificity was chosen, then if still multiple choices are found, the one with the highest
accuracy was finally taken. There was an exception for CN vs. MCI, the sensitivity
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Table 4.

Summary of Tenfold Cross Validation Performance
Improved after Combining Two Decision Spaces

Groups
Decision Space
ACC %
SEN %
SPE %
PPV %
NPV %
Number of the
optimal variables

CN vs. MCI
Left

CN vs. AD

Right Comb. Left

67.03
69.13
63.57
75.71
55.63

69.73 84.86
71.30 84.78
67.14 85.00
78.10 90.28
58.75 77.27
Left: 20
Right: 14

MCI vs. AD

Right Comb. Left

85.83
81.00
89.29
84.38
86.81

82.92 94.17
81.00 93.00
84.29 95.00
78.64 93.00
86.13 95.00
Left: 9
Right: 11

69.39
67.00
70.43
49.63
83.08

Right Comb.

66.67 81.82
66.00 83.00
66.96 81.30
46.48 65.87
81.91 91.67
Left: 2
Right: 4

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease,
Comb.: combining left and right ACC: accuracy, SEN: sensitivity, SPE: specificity, PPV:
positive predictive value, NPV: negative predictive value

continued increasing while adding more variables, and from the clinical point of view, the
higher sensitivity and the lower specificity would be preferred, therefore once the
sensitivity was greater than the specificity, the set with the highest accuracy was then
chosen.
As demonstrated in Fig. 2(a), for each side of the brain, the classification
performance for CN vs. MCI yielded average results just as other studies reviewed in [3]
have shown, where the sensitivity is 69.13% and 71.30% for each decision space (i.e., each
hemisphere), respectively. Moreover, after combining the results of the two decision spaces
together, the performance was significantly improved for all comparisons as shown in
Table 4, which are very competitive in comparison to results reported in other recent
studies [5, 6, 9] as indicated in Table 5.
Table 5.

Comparison of Cross Validation Performance with Some Recent Studies

Groups

CN vs. MCI
CN vs. AD
MCI vs. AD
Subjects
Modalities ACC SEN SPE ACC SEN SPE ACC SEN SPE
Reference
(CN+MCI+AD)
%
%
%
%
%
%
%
%
%
L. Xu et al.
MRI+FDG
117+110+113
74.50 66.40 82.10 94.80 95.60 94.00
[5], 2016
+PET
D. Zhang et al.
MRI+PET
52+99+51
76.40 81.80 66.00 93.20 93.00 93.30
[6], 2011
+CSF
L. Khedher et al.
229+401+188
MRI
81.89 82.16 81.62 88.49 91.27 85.11 87.3 88.65 85.41
[9], 2015
Proposed Study
190+305+133
MRI
84.86 84.78 85.00 94.17 93.00 95.00 81.82 83.00 81.30
CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease, ACC: accuracy, SEN: sensitivity, SPE:
specificity
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Table 6.

Summary of the Proposed GDA-based Generative
Learning Algorithm Classification Performance

Groups
Decision
Space
ACC %
SEN %
SPE %
PPV %
NPV %

CN vs. MCI
Left

59.32
63.38
53.19
67.16
49.02

CN vs. AD

MCI vs. AD

Right Comb. Left

Right Comb. Left

Right Comb.

63.56
64.79
61.70
71.88
53.70

73.08
70.97
74.47
64.71
79.55

63.73
61.29
64.79
43.18
79.31

82.20
83.10
80.85
86.76
76.00

78.21
70.97
82.98
73.33
81.25

85.90
83.87
87.23
81.25
89.13

64.71
41.94
74.65
41.94
74.65

75.49
64.52
80.28
58.82
83.82

CN: cognitively normal control, MCI: mild cognitive impairment, AD:
Alzheimer’s disease, Comb.: combining left and right ACC: accuracy, SEN:
sensitivity, SPE: specificity, PPV: positive predictive value, NPV: negative
predictive value

2.3.3. Classification Performance
By using the remaining 25% of the noise free data points as the held-out test data
(47 CN, 71 MCI, and 31 AD), the classification performance of the trained GDA-based
classifier (i.e., the obtained optimal set of variables) is presented in Table 6. Even though,
the classification performance was not as good as that in the tenfold cross validation, the
results obtained are still better than state-of-the-art-algorithms reviewed in [3], especially
for the challenging CN vs. MCI classification.
2.4. Discussion
The merits of the proposed GDA-based machine learning algorithm are not only
reflected through the good classification performance it achieved, but also in the way it
looked at the two hemispheres of the brain separately. The classification was performed to
two decision spaces (i.e., the left and right hemispheres of the brain), respectively, then as
long as one of them produces a positive result (MCI or AD), the given subject is classified
as a positive one. Since the boundaries have been obtained, it would be very effective to
classify a subject. As demonstrated in Fig. 3, the boundaries are nonlinear, which could not
be solved by other linear classification algorithms, such as, SVM and logistic regression.
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(a)

(b)
Fig. 3.
The Boundaries for the Classification of CN vs. MCI Using Top-2 Significant Variables: (a)
The multivariate Gaussian distribution of CN and MCI, and (b) The classification boundaries between CN
and MCI.

And taking advantage of the covariance matrix, the correlation of different variables is
taken into account by the proposed GDA-based algorithm, which are essentially important
and often being ignored in some probabilistic classification algorithms like Naive Bayes.
It ought to be noted that in this study, the classification performance has been
significantly improved by using only structural MRI data. But there are a lot of other
sensitive biomarkers to the progression of AD and MCI, including PET, CSF, among
others, to improve even further such classification results with a focus placed on CN vs.
MCI. What is unique in this approach is the fact that instead of building only one decision
space, the left and right hemispheres of the brain are separated into two decision spaces,
respectively. The original intention of this approach was quite simple, and is based on the
fact that every person has his or her dominant hand, and as such, right-handers use their
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left brain more than the right one, and vice versa. Hence, regarding the progression of AD
and MCI, the more frequently used side of the brain could be assumed to be affected more
than the less used side.
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CHAPTER III.

GAUSSIAN

DISCRIMINANT

ANALYSIS

FOR

OPTIMAL

DELINEATION OF MILD COGNITIVE IMPAIRMENT IN ALZHEIMER’S DISEASE
3.1. Goal
Over the past few years, several approaches have been proposed to assist in the
early diagnosis of AD and its prodromal stage of MCI. Using multimodal biomarkers for
this high-dimensional classification problem, the widely used algorithms continue to yield
unsatisfactory performance for delineating the MCI participants from the CN group. In this
chapter, we develop a machine learning classification algorithm based on the GDA,
introducing the use of dual decisional spaces, one for each hemisphere. Among those
modalities, structural MRI is currently widely used for analyzing the gradual progression
of atrophy patterns in key brain regions [35], therefore, this study makes use of structural
MRI as the unique input. To the best of our knowledge, this study is the first to apply GDA
to the diagnosis of CN vs. MCI by training dual decisional spaces simultaneously, with the
CN vs. AD classification results included here only for comparative purposes.
3.2. Methodology
Several software pipelines are used to preprocess the raw MRI data as a first step.
After the pre-processing step, morphometric (shape) data are derived from the images,
including shape measures of all 25 labeled cortical regions. Then a noise detection
procedure and a feature selection method based on the ANOVA are deployed to determine
the statistical significance of each variable in the classification outcome. Then, a GDAbased classifier applied on the dual decision spaces is proposed for solving the boundaries
between any two different groups of subjects (i.e., CN vs. MCI, CN vs. AD, and MCI vs.
AD). The general framework of the proposed algorithm is illustrated in Fig. 4.
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Test and Classification

Training and Cross Validation

Feature Selection Noise Detection

Image Pre-processing

Original MRI data

MRI data pre-processing
i.e., derive tables of
morphometric (shape) data
of all labeled cortical regions
Detect all abnormal variables
e.g., the measurements of
some regions with the value
of zero
Sort all features by p-value
based on the ANOVA
Choose features by the
incremental error analysis
Train the proposed GDA-based classifier and
derive boundaries in dual decision spaces

Test the obtained dual decision
spaces using held-out data

Fig. 4. General Framework of the GDA-based Dual High-dimensional Decision Spaces Algorithm.
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3.2.1. Subjects
The data used in preparation of this study were obtained from the Alzheimer’s
disease Neuroimaging Initiative (ADNI) database, as part of the ADNI1: Complete 1Yr
1.5T collection and their assessments at baseline, which includes 628 individuals (190 CN,
305 MCI, and 133 AD). The ADNI was launched in 2003 as a public-private partnership,
led by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI has been
to test whether serial MRI, PET, other biological markers, and clinical and
neuropsychological assessment can be combined to measure the progression of MCI and
early AD. The primary phenotype is diagnostic group and MMSE. All source imaging data
consisted of 1.5 Tesla T1-weighted MRI volumes in the NIfTI (.nii.gz) format. Summary
statistics and patient counts are listed in Table 1 as same as the one used in Chapter II.
3.2.2. MRI Data Pre-processing
Using three neuroimaging software pipelines: FreeSurfer [63], ANTs [64], and
Mindboggle [65], the original MRI data were preprocessed following the instruction
provided by Alzheimer's Disease Big Data DREAM Challenge #1 [66]. Tables of
morphometric data were derived from the images using the following seven shape
measures for all 25 FreeSurfer labeled cortical regions for both left and right hemispheres
of the brain: 1) surface area; 2) travel depth; 3) geodesic depth; 4) mean curvature; 5)
convexity; 6) thickness; and 7) volume. FreeSurfer pipeline (version 5.3) was applied to
all T1-weighted images to generate labeled cortical surfaces, and labeled cortical and noncortical volumes. Templates and atlases used by ANTs and Mindboggle can be found on
the Mindboggle website [67].
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3.2.3. Noise Detection
The preprocessed MRI data of the 25 labeled cortical regions were used to generate
two 175-variable (7 × 25) vector discriminators, for each subject (i.e., one 175-variable
vector per hemisphere). This study reveals that separating the variables for each
hemisphere of the brain yields a better classification performance than processing all
features together, with details in support of this assertion provided in the Section 3.3. As
for the few subjects whose vector discriminator involved atypical variables, for example,
some regions having measurements of some areas to be zero, these subjects were removed
from further investigation.
3.2.4. Feature Selection
By the final stage of AD, brain tissue has atrophied significantly, so all shape
measures mentioned above could have changed as well. Some of the subtle changes
initially appear to take place in some specific areas of the brain, so determination of the
key changed ROIs can help to discriminate more specifically MCI from CN.
3.2.4.1. ANOVA Ranking
An ANOVA was carried out on each of the 175 variables of the two vectors
between any two groups (i.e., CN vs. MCI, CN vs. AD, and MCI vs. AD) to determine the
significance of each variable in terms of classification outcome, and all variables were
thereafter ranked according to their p-values. It should be noted that in the feature selection
procedure, the Shapiro-Wilk test was employed for testing the normality of the shape
measures and the average p-value is 0.28, which indicates that the data are from a normally
distributed population [69]. Furthermore, equal weights are assigned to each of the shape
measures so as to eliminate any bias.
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3.2.4.2. Incremental Error Analysis
In order to maintain only few key variables and still ensure good classification
performance, an incremental error analysis was performed to determine how many of the
top-ranked variables ought to be included in the classifier [2]. In the initial phase, the
proposed GDA-based classifier only uses the first-ranked variable. The error analysis was
employed whereby introducing the next top-ranked variable in the classifier at each
subsequent phase, and recording the corresponding classification statistics (i.e., F1 score,
accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive
value (NPV)), which then would be compared with the previous phase. When the
performance in terms of its classification statistics can no longer be improved, the optimal
set of variables would have been obtained.
3.2.5. GDA-based Classifier
Since there may be as many as 175 variables to be taken into consideration, the
classifier must be able to resolve this high-dimensional classification problem. For this
reason, and by using GDA, an important supervised machine learning algorithm for such
classification problems, the proposed classifier is able to solve the boundaries between any
two groups (i.e., CN vs. MCI, CN vs. AD, and MCI vs. AD). The proposed classification
problem can then be formalized by having the machine learn to distinguish among CN
(𝑦 = 0), MCI (𝑦 = 1), and AD (𝑦 = 2), based on the selected features 𝑥 ∈ ℝ𝑛 . Then, given
a training set, the proposed algorithm can model 𝑝(𝑥|𝑦), the condition distribution of the
n-dimensional vector 𝑥 given 𝑦 ∈ {0,1,2}, assumed to be distributed according to a
multivariate Gaussian distribution (or multivariate normal distribution), whose density
function is given by (1) as below:
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𝑝(𝑥; 𝜇, Σ) =

1

1
(𝑥−𝜇)𝑇 Σ−1 (𝑥−𝜇)

√(2𝜋)𝑛 |Σ|

𝑒 −2

(1)

where 𝜇 ∈ ℝ𝑛 is the mean vector, Σ ∈ ℝ𝑛×𝑛 is the covariance matrix, the same as the one
used in other regression analysis methods (e.g., the principal component analysis), and
Σ 𝑎𝑛𝑑 Σ −1 denote the determinant and inverse matrix of Σ, respectively. Note that 𝑛 is the
dimension of vector 𝑥, i.e., the number of features included in the classifier. After modeling
𝑝(𝑥|𝑦), the proposed algorithm uses Bayes rule to derive subsequent distribution on 𝑦
given 𝑥 as follows:
𝑝(𝑦|𝑥) =

𝑝(𝑥|𝑦)𝑝(𝑦)
𝑝(𝑥)

(2)

Here, 𝑝(𝑦) is the class prior distribution, which could not be determined when given a
certain subject, so it is assumed to be absolutely random (i.e., for all 𝑖 ≠ 𝑗, 𝑝(𝑦 = 𝑖) =
𝑝(𝑦 = 𝑗)). Furthermore, in order to make a prediction, it is not necessary to calculate the
denominator 𝑝(𝑥), since
arg max 𝑝(𝑦|𝑥) = arg max
𝑦

𝑦

𝑝(𝑥|𝑦)𝑝(𝑦)
= arg max 𝑝(𝑥|𝑦)𝑝(𝑦)
𝑦
𝑝(𝑥)

(3)

Therefore, for the purpose of classification, it only needs
arg max 𝑝(𝑦|𝑥) = arg max 𝑝(𝑥|𝑦)
𝑦

𝑦

(4)

The classifier was applied to each hemisphere of the brain (using the two 175-variable
vectors), and if either one of the two sides had been classified to be positive, the
corresponding subject should be positive as well.
The performance of the proposed classifier was measured using the F1 score,
accuracy, sensitivity, specificity, PPV, and NPV based on a tenfold cross validation
process. For selecting the optimal set of variables, 80% of the noise-free detected subjects’
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data was used as the training set in a tenfold cross validation process, which were randomly
assigned to ten subsets 𝑑0 , 𝑑1 , … , 𝑑9, so that all subsets were of equal size. Then one of
each of the ten sets was retained as the validation dataset, while the remaining nine datasets
were used as training data; thus, every data point was used for both training and validation
on each fold. Once the optimal set of variables was generated, the classification
performance was evaluated by using the remaining 20% of the noise-free detected subject
data points as the held-out test set.
As demonstrated in Fig. 5, data of the left and right hemispheres of the brain were
processed separately, which means, for the final classification, each hemisphere had its
own decision space, and as long as one decision space produces the positive result (i.e.,
MCI in CN vs. MCI, AD in CN vs. AD, and AD in MCI vs. AD), the tested subject is
classified as such. This innovative process resulted in a significant improvement of the
classification performance as demonstrated in the Section 3.3, especially for the most
challenging classification of CN vs. MCI.

Fig. 5. Flowchart of the GDA-based Dual Decision Space Classification Process.
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3.3. Results
In this section, the experimental results of the feature selection process reveal the
significance of different ROIs in patients for the three classification types: 1) CN vs. MCI;
2) CN vs. AD; and 3) MCI vs. AD. Evolution in the statistics during the incremental error
analysis and the classification performance of the GDA-based algorithm using the
proposed dual decisional spaces are provided.
3.3.1. Ranking of the Variables
After the noise detection process was applied, 9 subjects were removed because of
the noisy data, which included measurements with zero values, so the final data used in the
classification experiment included 619 individuals, among them, 187 CN, 301 MCI, and
131 AD. As mentioned earlier, ANOVA was performed for CN vs. MCI, CN vs. AD, and
MCI vs. AD using two 175-variable vectors corresponding to the left and right hemispheres
of the brain. For each group, all variables found at 0.01 LOS out of all 175 variables for
each side of the brain (i.e., those variables with p-values less than 0.01) were used for the
classification as shown in Table 2 as same as those used in Chapter II.
The top 10 ranked variables and their corresponding measurements are given in
Table 7, where it can be observed that the entorhinal cortex is the most significant (firstranked) cortical region for discriminating either MCI or AD from CN. This observation is
consistent with recent studies indicating that indeed the entorhinal cortex is the first area
to be implicated in AD [36-38], providing credence to the validity of our feature selection
method. Moreover, the entorhinal cortex has been proven to be a major source of
projections to the hippocampus [68], which plays an important role in converting shortterm memory (also known as working memory) to long-term memory. Interestingly, for
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Table 7.
Groups
Side of
brain

CN vs. MCI

CN vs. AD

MCI vs. AD

Rank

Measurements

p-value

Measurements

p-value

Measurements

p-value

1

Thickness of entorhinal

< 10-17

Thickness of entorhinal

< 10-36

< 10

6

Thickness of fusiform

< 10-8

7

Curvature of insula

< 10-8

Curvature of entorhinal
Thickness of middle
temporal
Thickness of inferior
temporal
Curvature of middle
temporal
Thickness of inferior
parietal
Curvature of inferior
temporal

< 10

5

Curvature of entorhinal
Thickness of middle
temporal
Thickness of inferior
temporal
Curvature of middle
temporal

-26

< 10-8

Thickness of fusiform

< 10-16

< 10-8

Curvature of entorhinal

< 10-5

< 10-6

Curvature of
parahippocampal
Curvature of inferior
parietal

< 10-15

10

Curvature of
parahippocampal
Curvature of inferior
temporal
Thickness of superior
temporal

Thickness of inferior
parietal
Thickness of entorhinal
Thickness of middle
temporal
Thickness of inferior
temporal
Volume of inferior
parietal
Curvature of middle
temporal
Curvature of inferior
parietal
Volume of inferior
temporal

< 10-8

-13

< 10-14

< 10-5

1

Thickness of entorhinal

< 10-13

Thickness of entorhinal

< 10-31

Volume of middle
temporal
Curvature of middle
temporal

2

Thickness of middle
temporal

< 10-10

< 10-25

Thickness of entorhinal

< 10-8

3

Thickness of fusiform

< 10-10

Thickness of middle
temporal
Curvature of middle
temporal

< 10-22

< 10-7

< 10-8

Curvature of entorhinal

< 10-21

5

Curvature of middle
temporal
Curvature of superior
temporal

< 10-8

< 10-18

6

Curvature of entorhinal

< 10-8

< 10-18

Curvature of entorhinal

< 10-6

7

Curvature of fusiform

< 10-8

Thickness of inferior
parietal
Curvature of inferior
temporal
Thickness of inferior
temporal

Thickness of middle
temporal
Volume of inferior
parietal
Curvature of inferior
temporal

< 10-17

< 10-6

Thickness of superior
frontal
Thickness of inferior
temporal
Curvature of superior
frontal

< 10-7

Thickness of fusiform

< 10-17

< 10-7

Curvature of inferior
parietal

< 10-15

< 10-7

Curvature of fusiform

< 10-15

Thickness of inferior
parietal
Volume of middle
temporal
Volume of inferior
temporal
Thickness of inferior
temporal

2
3
4

Left

Top-10 Significant Variables for Each Comparison.

8
9

4
Right

8
9
10

< 10-12
< 10-10
< 10-9

< 10-24
< 10-22
< 10-21
< 10-18
< 10-16

< 10-7
< 10-6
< 10-6
< 10-6
< 10-6
< 10-6
< 10-6

< 10-8

< 10-6
< 10-6

< 10-5
< 10-5
< 10-5

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease

discriminating MCI from AD, the entorhinal cortex is relegated to the second top-ranked
region.
Although the hippocampus area does not appear to be of higher significance than
the entorhinal cortex in the feature selection process, it could still serve as an explanation
for the symptom of AD in that short-term memory loss occurs earlier than long-term
memory loss. Since, at the very beginning, direct connections to the hippocampus seem to
have been affected. The second top-ranked cortical region, the middle temporal, is also
critical for long-term memory, to which the disrupted hippocampal connectivity has been
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Fig. 6. Relative Location of Hippocampus and the Top-three-ranked Cortical Regions (visualized with the
BrainNet Viewer [71]).

found in the early stages of AD [70]. Moreover, in the human brain, all top three-ranked
cortical regions, including the entorhinal, the middle temporal, and the inferior temporal
are very close to the hippocampus as shown in Fig. 6. From Table 7, it also can be observed
that for discriminating between MCI and AD, the significant variables are now much
different to others. Hence, for the tenfold cross validation and the incremental error
analysis, all three classifications were trained and validated separately in order to achieve
the best performance.
3.3.2. Optimal Sets of Variables
To generate the optimal sets of variables, in the tenfold cross validation, the
aforementioned 80% of the noise-free detected data points included 500 individuals (150
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CN, 240 MCI, and 110 AD), where all numbers were rounded to the nearest number
divisible by 10 for the tenfold cross validation of the noise-free detected subjects included
in this study (i.e., 619 = 187 CN + 301 MCI + 131 AD).
The purpose of applying the incremental error analysis was to obtain the best
classification performance with the optimal number of variables (i.e., the number of
dimensions in the decisional spaces). For each hemisphere, some classification statistics
are illustrated in Fig. 7, where the horizontal axis indicates the number of significant
variables included in each iteration.

(a)

(b)

(c)
Fig. 7. Incremental Error Analysis Performance of Classification Statistics: (a) CN vs. MCI, (b) CN vs. AD,
and (c) MCI vs. AD.

29

In the tenfold cross validation and in the subsequent true test, four important
parameters were computed, including the number of True Positives (TP) (i.e., the correctly
classified positive subjects), the number of True Negatives (TN) (i.e., the correctly
classified negative subjects), the number of False Positive (FP) (i.e., the negative subjects
incorrectly classified as positive), and the number of False Negative (FN) (i.e., the positive
subjects incorrectly classified as negative). For evaluating the classification performance,
the following commonly used measures are computed for determining accuracy (5),
sensitivity (6), specificity (7), positive predictive value - PPV (8), and negative predictive
value - NPV (9):
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝐹𝑃 + 𝑇𝑁 + 𝐹𝑁

(5)

𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =

𝑇𝑃
𝑇𝑃 + 𝐹𝑁

(6)

𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =

𝑇𝑁
𝑇𝑁 + 𝐹𝑃

(7)

𝑃𝑃𝑉 =

𝑇𝑃
𝑇𝑃 + 𝐹𝑃

(8)

𝑁𝑃𝑉 =

𝑇𝑁
𝑇𝑁 + 𝐹𝑁

(9)

But due to the effect of imbalanced data, and as a clinical application, the classification
performance was not only measured by the accuracy, which actually relies more on the
sensitivity or recall and the PPV or precision, but also by using the F1 score, as expressed
below, in order to select the optimal sets of variables,
𝐹1 =

2 × 𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 × 𝑃𝑃𝑉
2𝑇𝑃
=
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 + 𝑃𝑃𝑉
2𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁
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(10)

(a)

(b)

(c)
Fig. 8. Simultaneous Incremental Error Analysis Performance of F1 Score: (a) CN vs. MCI, (b) CN vs.
AD, and (c) MCI vs. AD.
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As the harmonic mean of sensitivity and PPV, the F1 score or balanced F-score is the
widely used measure of performance in statistical analysis of binary classification. For the
incremental error analysis (IEA), the set with the highest F1 score was selected, when
several sets had the same F1 score, the one with the highest accuracy was chosen, then if
still multiple choices were found, the one having the minimum size was finally selected.
As demonstrated in Fig. 7(a), for either one of the two hemispheres of the brain, the
classification performance for CN vs. MCI yielded better than the average results obtained
from other studies reported in [3], where the sensitivity is 78.75% and 77.50% for each
decision space (i.e., each hemisphere), respectively. After combining the results of the two
decisional spaces together and simultaneously implementing the incremental error analysis
again, the evolution of the F1 score is as illustrated in Fig. 8.
It can be observed that the final optimal sets are different from the ones obtained
for each hemisphere before combining the two decision spaces together. For all
comparisons, the performance was improved significantly as shown in Table 8. Moreover,
for the most difficult two groups to delineate, CN vs. MCI, significant enhancements in
classification statistics were achieved, including an increase in F1 score average from
73.82% to 92.08% and increments of 24.37% for accuracy, 13.96% for sensitivity, 41.00%
for specificity, 22.11% for PPV, and 30.37% for NPV, respectively. Comparatively to the
more recently reported cross validation performances of some of the state-of-the-artapproaches [8-10, 12, 14, 32, 72], the proposed study achieves remarkable improvements
in performance, especially in delineating MCI from CN, even when MRI is the only
modality used for this study. As shown in Table 9, except for the specificity of the CN vs.
MCI classification and the sensitivity of the MCI vs. AD classification, the proposed
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Table 8.
Summary of Tenfold Cross Validation Performance
Improved after Combining the Dual Decision Spaces
Groups
Decision Space
F1 %
ACC %
SEN %
SPE %
PPV %
NPV %
Number of the
optimal variables

CN vs. MCI
Left Right Comb.
73.83 73.81 92.08
65.64 66.15 90.26
78.75 77.50 92.08
44.67 48.00 87.33
69.49 70.45 92.08
56.78 57.14 87.33
L: 5
36
34
R: 44

CN vs. AD
Left Right Comb.
82.03 83.18 95.89
85.00 86.15 96.54
80.91 80.91 95.45
88.00 90.00 97.33
83.18 85.58 96.33
86.27 86.54 96.69
L: 10
6
5
R: 44

MCI vs. AD
Left Right Comb.
56.59 55.00 81.41
68.00 69.14 89.43
66.36 60.00 73.64
68.75 73.33 96.67
49.32 50.77 91.01
81.68 80.00 88.89
L: 48
2
2
R: 4

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease,
Comb.: combining left and right, ACC: accuracy, SEN: sensitivity, SPE: specificity, PPV: positive
predictive value, NPV: negative predictive value

Table 9.

Comparison of Cross Validation Performance with Some Recent Studies

Groups
Reference

Modalities Classifier

M. Liu et al. [8],
2012

MRI

SRC

L. Khedher et al.
[9], 2015

MRI

SVM

T. Ye et al. [10],
MRI + PET
2016
MRI + PET
T. Tong et al.
+ CSF
[12], 2017
+ Genetic
L. Khedher et al.
MRI
[14], 2017
A. Ortiz et al.
MRI
[72], 2017
Proposed Study

MRI

SVM

CN vs. MCI
Source of Data
ACC SEN SPE
(CN+MCI+AD)
%
%
%
ADNI
(229 + 225 + 87.85 85.26 90.40
198)
ADNI
(229 + 401 + 81.89 82.61 81.62
188)
ADNI
82.13 87.68 71.54
(52 + 99 + 51)
ADNI
(35+75+37)

RF
SVM
DBN
GDA

ADNI
(-)
ADNI
(-)
ADNI
(190 + 305 +
133)

CN vs. AD
MCI vs. AD
ACC SEN SPE ACC SEN SPE
%
%
%
%
%
%
90.80 86.32 94.76

-

-

-

88.49 91.27 85.11 85.41 87.03 83.78
95.92 94.71 97.12

-

-

-

79.50 85.10 67.10 91.80 88.90 94.70
79.00 82.00 76.00 89.00 92.00 86.00 85.00 85.00 86.00
83.00

-

-

90.00

-

-

84.00

-

-

90.26 92.08 87.33 96.54 95.45 97.33 89.64 84.29 90.67

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease, Comb.: combining left and right, ACC:
accuracy, SEN: sensitivity, SPE: specificity, PPV: positive predictive value, NPV: negative predictive value

method yielded the best cross validation performance in a comparative assessment to all
other methods.
3.3.3. Classification Performance
In order to obtain a reliable measure of the classification performance, the
remaining 20% of the noise-free detected data points were used as the held-out test data
(37 CN, 61 MCI, and 21 AD) using the obtained optimal sets of variables. The results are
presented in Table 10. Although the classification performance was not as good as that
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Table 10.

Classification Performance of the Proposed GDA-based Dual Highdimensional Decision Space Algorithm

Groups
Decision Space
ACC %
SEN %
SPE %
PPV %
NPV %

Table 11.
Groups
Reference
R. Cuingnet et al.
[3], 2011
H. Aidos et al.
[12], 2017
Proposed Study

CN vs. MCI
Left Right Comb.
55.10 52.04 80.61
73.77 65.57 81.97
24.32 29.73 78.38
61.64 60.61 86.21
36.00 34.38 72.50

CN vs. AD
Left Right Comb.
75.86 70.69 93.10
71.43 66.67 90.48
78.38 72.94 94.59
65.22 58.33 90.48
82.86 79.41 94.59

MCI vs. AD
Left Right Comb.
65.85 67.07 85.37
42.86 38.10 52.38
73.77 77.05 96.72
36.00 36.36 84.62
78.95 78.33 85.51

Comparison of Classification Performance Using Held-out Test Data
CN vs. MCI
CN vs. AD
Modalities Classifier ACC SEN SPE PPV NPV ACC SEN SPE PPV NPV
%
%
%
%
%
%
%
%
%
%
MRI

SVM

-

73.00 74.00 56.00 86.00

PET

SVM

61.90 54.70 69.20

MRI

GDA

80.61 81.97 78.38 86.21 72.50 93.10 90.48 94.59 90.48 94.59

-

-

-

82.00 89.00 86.00 86.00

84.40 76.90 91.90

-

-

CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease, Comb.: combining left and right, ACC:
accuracy, SEN: sensitivity, SPE: specificity, PPV: positive predictive value, NPV: negative predictive value

obtained in the tenfold cross validation, the results are still better than state-of-the-artalgorithm reviewed in [3] and the recently proposed state-of-the-art approach in [12], as
shown in Table 11. Since not all studies implemented the held-out true test, only the results
from [3] and [12] were considered for comparison to our proposed method, which also
used ADNI data. For discriminating AD from CN, the proposed GDA-based algorithm
achieved an accuracy of 93.10%, sensitivity of 90.48%, specificity of 94.59%, PPV of
90.48%, and NPV of 94.59%; these results for these two groups were expected. But more
importantly, an accuracy of 80.61%, sensitivity of 81.97%, specificity of 78.38%, PPV of
86.21%, and NPV of 72.50% were obtained for discriminating MCI from CN; results that
are considered as the best classification performance obtained so far using the GDA
method.
3.4. Discussion
The merits of the proposed GDA-based dual decision space algorithm are not only
reflected through the good classification performance it achieved, but also in the strategic
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way it looked at the two hemispheres of the brain separately. The classification was
performed using dual decision spaces (i.e., the left and right hemispheres of the brain),
respectively, then as long as one of them produces a positive result (MCI or AD), the given
subject is classified as a positive one. Since the boundaries have been obtained, it would
be very effective to classify a subject. A normality test was conducted, which proved that
the original data were normally distributed; therefore, GDA was the method of choice as a
more efficient way to address the anticipated nonlinear boundaries between the different
groups (CN, MCI and AD).
Empirical evaluations demonstrated that the proposed GDA-based algorithm, as
illustrated in Fig. 9, proved to be easier for implementation and provided better results than
logistic regression and SVM with Gaussian or RBF kernel. And taking advantage of the

(a)

(b)
Fig. 9. The GDA-based Dual High-dimensional Decision Spaces for CN, MCI, and AD with Top-two Ranked
Features: (a) Multivariate Gaussian distribution, and (b) Classification boundaries.
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covariance matrix, the correlation of different variables is considered by the proposed
GDA-based classifier, which is deemed essentially important and often ignored in some
probabilistic classification algorithms like Naive Bayes. It ought to be noted that in this
study, the classification performance has been improved significantly by using only
structural MRI data. Evidently, there are many other sensitive biomarkers including PET,
CSF, EEG, among others, and some cognitive markers like failure to recover from
proactive interference (frPSI) [44], that could be integrated in the proposed analysis that
made use of only MRI measurements. In a multimodal neuroimaging approach, diagnosis,
prediction and classification of AD are all processes that would be greatly enhanced, with
a focus placed on the early detection of the MCI stage and hence timely planning of
therapeutic interventions and treatment [34].
So far, most of the current investigations assumed only binary or two-way
classification, where validation experiments were based on two-group comparisons, i.e.,
CN vs. MCI, CN vs. AD, and MCI vs. AD. Such binary classifications limit the clinical
diagnosis for a given patient, which could belong in any of the three groups. In those threeway classification studies, the performance is still not insufficient, which can achieve the
overall accuracy around 60% [14]. The proposed algorithm is not able to implement threeway classification yet, therefore, more efforts and further investigations need to be
concentrated on the multimodal multi-class classification of different stages of AD for our
future work.
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CHAPTER IV.

A NOVEL GAUSSIAN DISCRIMINANT ANALYSIS-BASED

COMPUTER AIDED DIAGNOSIS SYSTEM FOR SCREENING DIFFERENT STAGES
OF ALZHEIMER’S DISEASE
4.1. Goal
This chapter aims to introduce a novel classification algorithm that relies on a
global feature selection, with the dual purpose of improved classification accuracy as well
as enhanced prospects for its seamless integration into a computer aided diagnosis (CAD)
system. Thus, instead of extracting different sets of features for those three comparisons
(CN vs. MCI, CN vs. AD, and MCI vs. AD), respectively, in this study, only one optimal
set of features will be generated. This proposed global feature selection indicates that the
entorhinal cortex is the most significant cortical region associated with the progression of
AD, which is consistent with recent studies concluding that the entorhinal cortex is the
signature region to be implicated in AD [36-38, 73, 74]. Furthermore, by deploying left
and right hemispheres of the brain into two distinct decision spaces, the classification
performance is improved significantly.
4.2. Materials
The information of the subjects used in this study and the MRI data pre-processing
procedure are presented in this section.
4.2.1. Subjects
The data used in the preparation of this study were obtained from the Alzheimer’s
disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was
launched in 2003 as a public-private partnership, led by Principal Investigator Michael W.
Weiner, MD. The primary goal of ADNI has been to test whether serial MRI, PET, other
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biological markers, and clinical and neuropsychological assessment can be combined to
measure the progression of MCI and early AD. As part of the ADNI1: Complete 1Yr 1.5T
collection and their assessments at baseline, the data include 628 individuals (190 CN, 305
MCI, and 133 AD). The primary phenotype is diagnostic group and Mini–Mental State
Examination (MMSE). All source imaging data consist of 1.5 Tesla T1-weighted MRI
volumes in the NIfTI (.nii.gz) format from the ADNI1: Complete 1Yr 1.5T Data
Collection. Summary statistics and patient counts are listed in Table 1 as same as the one
used in Chapter II and Chapter III.
4.2.2. MRI Data Pre-processing
Following the instruction provided by Alzheimer's Disease Big Data DREAM
Challenge #1 [66], the original MRI data were pre-processed using three neuroimaging
software pipelines: FreeSurfer [63], ANTs [64], and Mindboggle software [65]. Tables of
morphometric data were derived from the images, including seven shape measures for all
25 FreeSurfer labeled cortical regions for both left and right hemispheres of the brain: 1)
surface area; 2) travel depth; 3) geodesic depth; 4) mean curvature; 5) convexity; 6)
thickness; and 7) volume. All T1-weighted images were processed by FreeSurfer pipeline
(version 5.3) in order to generate labeled cortical surfaces, and labeled cortical and
noncortical volumes. Templates and atlases used by ANTs and Mindboggle could be found
on the Mindboggle website [67].
4.2.3. Noise Detection
For each subject, the pre-processed MRI data of the 25 labeled cortical regions were
used to obtain two 175-feature (725) vector discriminators corresponding to left and right
hemisphere of the brain, respectively. Manipulating the features of each hemisphere
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separately is shown to yield a better classification performance, of which details in support
of this assertion can be found in the Results section. Any subjects with abnormal variables
were eliminated from further investigation, for example, some of their cortical regions
having measurements of some features to be zero.
4.3. Methods
In this section, the classification algorithm with global feature selection is presented
for the early diagnosis of AD. The global feature selection method based on the ANOVA
and the incremental error analysis are employed to determine the statistical significance of
each feature in the classification outcome. A GDA-based classifier is then proposed for
resolving the typical binary classification problem and introducing a CAD system for AD.
4.3.1. Global Feature Selection
Brain tissue has atrophied significantly at the final stage of AD, so all
aforementioned shape measures could have changed as well. But in early onset of AD, the
disease initially impacts only some specific regions of the brain, thus, determination of the
key changes in ROIs can help achieve more specific diagnosis of different stages of AD.
4.3.1.1. Global Feature Ranking
Instead of performing the ANOVA on each of the 175 features of the two brain
hemispheres between any two groups (i.e., CN vs. MCI, CN vs. AD, and MCI vs. AD), in
the global feature selection scenario , the ANOVA was carried out on each of the 175
features of the two brain hemispheres between all three groups (CN, MCI and AD) to
determine the significance of each feature in terms of classification outcome, and all
features were thereafter ranked according to their p-values. Accordingly, only one set of
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global features is obtained corresponding to each hemisphere of the brain. In order to
eliminate any bias, equal weights were assigned to each of the shape measures.
4.3.1.2. Incremental Error Analysis
In order to maintain the few but essential features for achieving the best
classification performance, an incremental error analysis was deployed for deciding how
many of the top-ranked features ought to be involved in the final classifier. In the initial
phase, the classifier only used the first-ranked feature, and the next top-ranked feature is
thereafter introduced in the classifier at each subsequent phase, and recording the
corresponding classification statistics, which then would be compared with the previous
phase, until all essential features are determined. In this study, as a machine learning
classification problem, the performance was estimated by the F1 score, and when the
performance can no longer be improved, then the optimal set of essential features would
have been obtained. The F1 score used for selecting the optimal sets of features is expressed
as Equation (10) in Chapter III. It should be noted that as a clinical application, the
classification performance may not only be measured by the accuracy, but actually relies
more on the sensitivity and PPV.
4.3.2. GDA-based Classifier
Since the classifier may have as many as 175 features to be taken into consideration,
it must be able to deal with high-dimensional data. Due to this reason, GDA, an important
generative learning algorithm for high dimensional classification problems, has been used
to establish the proposed classifier capable of recognizing the different patterns between
any given groups. The detailed definition and formulas of the GDA classifier used in this
study can be found in Chapter III, Section 3.2.5.
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Fig.10. General Flowchart of the CAD System Based on the Proposed Classification Algorithm.

4.3.3. Classification Experiments
The performance of the proposed classification algorithm was measured by using
the F1 score, accuracy, sensitivity, specificity, PPV, and NPV, based on a tenfold crossvalidation process using 80% of the noise-free detected subject data points. All data points
were randomly assigned to ten sets 𝑑0 , 𝑑1 , …, 𝑑8 and 𝑑9 , so that all sets were of equal size.
Then each one of the 10 sets was retained as the validation data while the remaining 9 sets
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were used as training data. Therefore, on each fold, each data point was used for both
training and validation. After the optimal sets of features were obtained, the remaining 20%
of the noise-free detected data were utilized to estimate the classification performance.
The typical binary classification implemented in the past assumed two different
groups of subjects at a time (i.e., CN vs. MCI, CN vs. AD and MCI vs. AD). However, for
reasons explained earlier on the limited clinical use of such binary classifications, on the
basis of a tenfold cross validation and a held-out test data set, this study implements a CAD
system with a new classification process, where the CN group is delineated form the
combined MCI and AD groups as a first classification phase, followed by the delineation
of the MCI group in the second phase, using strategically the two hemispheres of the brain
as distinct dimensional spaces in the decision process as shown in Fig. 10. It should be
noted that the data of the left and right hemispheres of the brain were processed separately,
except when we are generating the optimal set of features during the combined training of
the GDA-based classifier. Furthermore, for the proposed classification algorithm, each
hemisphere had its own decision space, and as long as one decision space produced a
positive result, the tested subject should be classified as positive as well. This procedure
could be considered as an innovative method, through which the classification performance
is significantly improved as presented in the following section.
4.4. Results
The experimental results of the global feature selection reveal what are the most
significant ROIs associated with the progression of AD. The evolution of all statistics in
the incremental error analysis and the performance of the proposed classification algorithm
are also presented.
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4.4.1. Top-ranked Global Features
After pre-processing the original MRI images, 9 subjects were eliminated because
of the noisy data which included measurements with zero values. Thus, the final data used
in the classification experiment included 619 individuals, among them 187 CN, 301 MCI,
and 131 AD. As mentioned earlier, ANOVA was carried out on the two sets of 175-feature
vectors corresponding to the left and right hemispheres of the brain between all three
groups. All features found at 0.01 LOS out of all 175 measurements for each side of the
brain were then used in the classification experiment as shown in Table 12.
The top-10 ranked features of each hemisphere of the brain are given in Table 13.
Revealed from this table, the entorhinal cortex is the most significant cortical region
associated with the progression of AD in both hemispheres of the brain. This observation
Table 12.
Side of brain
Left
Right

Number of Significant Features Selected
Number of significant features (p-value < 0.01)
71
66

Table 13.
Side of brain

Left

Right

Rank
1
2
3
4
5
6
7
8
9
10
1
2
3
4
5
6
7
8
9
10

Top-10 Ranked Features
Measurements
Thickness of entorhinal
Thickness of middletemporal
Curvature of entorhinal
Thickness of inferior temporal
Curvature of middle temporal
Thickness of inferior parietal
Thickness of fusiform
Curvature of inferior temporal
Curvature of parahippocampal
Curvature of inferior parietal
Thickness of entorhinal
Thickness of middle temporal
Curvature of middle temporal
Curvature of entorhinal
Thickness of fusiform
Curvature of inferior temporal
Thickness of inferior parietal
Thickness of inferior temporal
Curvature of fusiform
Curvature of inferior parietal
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p-value
< 10-33
< 10-24
< 10-24
< 10-21
< 10-20
< 10-18
< 10-16
< 10-16
< 10-14
< 10-14
< 10-29
< 10-24
< 10-22
< 10-19
< 10-17
< 10-17
< 10-16
< 10-16
< 10-15
< 10-14

is consistent with recent studies indicating that indeed the entorhinal cortex is the first area
to be implicated in AD [36-38]. Moreover, the entorhinal cortex has been proven as a major
source of projections to the hippocampus [68], which plays an important role in converting
short-term memory (also known as working memory) to long-term memory in the brain.
The second top-ranked cortical region, the middle temporal, is also critical for long-term
memory, to which the disrupted hippocampal connectivity has been found in the early
stages of AD [70]. Involving the other three significant ROIs identified from the global
feature ranking, the inferior temporal, fusiform, and parahippocampal, all top-5 ranked
features are AD signature regions investigated previously [73], which provide credence to
the validity of our global feature ranking method.
4.4.2. Optimal Feature Sets
The purpose of applying the incremental error analysis is to obtain the best
classification performance with only few but essential features (i.e., the dimensional degree
of the decision spaces). For generating the optimal feature sets, the tenfold cross validation
retained 80% of the noise-free detected subjects included in this study (i.e., 619 = 187 CN
+ 301 MCI + 131 AD), involving 500 individuals (150 CN, 240 MCI, and 110 AD), all
numbers were rounded to the nearest number divisible by 10 for the tenfold cross
validation.
As mentioned in the Section 4.3, the performance of the proposed classification
algorithm was estimated by the two-phase classification strategy that overcame the typical
binary classification process. This facilitated the design of the CAD system shown in Fig.
10, and improved the classification results, especially as it pertains to the challenging
delineation of MCI from the CN group. Therefore, for the tenfold cross validation, Fig. 11
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(a)

(b)

(c)

(d)
Fig. 11.
Incremental Error Analysis Performance of Classification Statistics for Each Hemisphere: (a)
CN vs. MCI, (b) CN vs. AD, (c) CN vs. MCI and AD, and (d) MCI vs. AD.

illustrates the evolution of some main classification statistics of each hemisphere, where
the horizontal axis indicates the number of top-ranked significant features included in each
iteration.
After combining the results of the two decision spaces together by the proposed
CAD system, the evolution of F1 score of the three critical CAD classifications is thereafter
demonstrated in Fig. 12. It can be observed that the final optimal feature sets are different
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(a)

(b)

(c)
Fig. 12.
Combining Incremental Error Analysis Performance of F1 Score: (a) CN vs. MCI and AD,
(b) CN vs. MCI, and (c) MCI vs. AD.

from the ones obtained for each hemisphere before combining the two decision spaces. For
each case, the classification performance was improved significantly as shown in Table 14.
For delineating MCI from CN, significant enhancements in classification statistics were
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Table 14.

Summary of the Tenfold Cross Validation Performance

CN vs. MCI
CN vs. AD
CN vs. MCI and AD
MCI vs. AD
Classification
Left
Right Comb.
Left
Right Comb.
Left
Right Comb.
Left
Right Comb.
Decision Space
76.21 76.63 95.30 82.03 81.73 96.23 83.33 84.70 97.20 55.91 55.56 79.82
F1 %
64.62 65.13 94.10 85.00 85.38 96.92 74.00 75.00 96.00 68.00 68.29 87.43
ACC %
92.08 92.92 97.08 80.91 77.27 92.73 92.86 98.86 99.14 64.55 58.18 79.09
SEN %
20.67 20.67 89.33 88.00 91.33 100.0 30.00 19.33 88.67 69.58 72.92 91.25
SPE %
65.00 65.20 93.57 83.18 86.73 100.0 75.58 74.09 95.33 49.31 49.61 80.56
PPV %
62.00 64.58 95.04 86.27 84.57 94.94 64.29 87.88 97.79 81.07 79.19 90.50
NPV %
Number of the
L: 69
L: 4
L: 67
L: 27
64
65
6
4
50
61
6
1
optimal features
R: 1
R: 42
R: 1
R: 1
CN: cognitively normal control, MCI: mild cognitive impairment, AD: Alzheimer’s disease, L: left hemisphere, R: right
hemisphere, Comb.: combining left and right, ACC: accuracy, SEN: sensitivity, SPE: specificity, PPV: positive predictive
value, NPV: negative predictive value.

achieved, including an increase in F1 score average from 76.42% to 95.30% and
increments of 29.23% for accuracy, 4.58% for sensitivity, 68.66% for specificity, 28.47%
for PPV, and 31.75% for NPV, respectively. For discriminating MCI and AD together from
CN group, an average increment of 24.03% for all classification statistics was obtained.
4.4.3. Classification Performance on Held-out Test Data
In order to obtain a reliable measure of the proposed classification algorithm
performance, the remaining 20% of the noise-free detected data points were used as the
held-out test data. Taking advantage of the obtained optimal sets of global features, the true
test results are shown in Table 15. The classification performance was not as good as that
achieved in the tenfold cross validation, but for the typically binary classification, the
reported results are still very competitive in comparison to results reported in other recent
studies also using ADNI database [12, 75], as indicated in Table 16. In comparison to such
recent studies, the obtained results in delineating the MCI from CN are significantly
Table 15.

Summary of the Classification Performance
using the Held-out Test Data

Classification
ACC % SEN % SPE % PPV % NPV %
CN vs. MCI
88.78
91.08
83.78
90.32
86.11
CN vs. AD
93.10
90.48
94.59
90.48
94.59
CN vs. MCI and AD 93.28
98.78
81.08
92.05
96.77
MCI vs. AD
81.71
71.43
85.25
62.50
89.66
CN: cognitively normal control, MCI: mild cognitive impairment, AD:
Alzheimer’s disease, ACC: accuracy, SEN: sensitivity, SPE: specificity,
PPV: positive predictive value, NPV: negative predictive value.
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Table 16.
Comparison of Binary Classification
Performance with Some Recent Studies Using ADNI Data
CN vs. MCI
CN vs. AD
Classification
ACC % SEN % SPE % ACC % SEN % SPE %
Reference
H. Aidos et al., [12], 2017 61.90 54.70 69.20 84.40 76.90 91.90
J. Zhang et al., [75], 2017 79.02 90.46 59.90 88.30 79.61 93.69
88.78 91.08 83.78 93.10 90.48 94.59
Proposed Study
CN: cognitively normal control, MCI: mild cognitive impairment, AD:
Alzheimer’s disease, ACC: accuracy, SEN: sensitivity, SPE: specificity, PPV:
positive predictive value, NPV: negative predictive value.

improved with an accuracy of 88.78%, a sensitivity of 91.08%, and a specificity of 83.78%,
which are even more effective than the results achieved for discriminating AD from CN in
those studies. For the CN vs. AD classification, performance improvement is also attained,
especially for the sensitivity, where the proposed algorithm yielded an average increment
of 12.23%. For delineating MCI and AD together from CN, an accuracy of 93.28%, a
sensitivity of 98.78%, a specificity of 81.08%, PPV of 92.05%, and NPV of 96.77% were
obtained. Then, an accuracy of 81.71%, a sensitivity of 71.43%, a specificity of 85.25%,
PPV of 62.50%, and NPV of 89.96% were accomplished for discriminating AD from MCI.
These results can be considered as the best CAD system performance achieved so far,
which also suggest a high potential of the proposed CAD system to be applied as a practical
clinical screening test for AD.
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CHAPTER V.
EARLY

GAUSSIAN DISCRIMINATIVE COMPONENT ANALYSIS FOR

DETECTION

OF

ALZHEIMER’S

DISEASE:

A

SUPERVISED

DIMENSIONALITY REDUCTION ALGORITHM
5.1. Goal
This chapter aims to introduce a novel supervised dimensionality reduction
algorithm to characterize the important Gaussian discriminative components with respect
to the structural, functional or metabolic measurements as observed in the MRI-PET
combination associated with different stages of AD, focusing on the prodromal stage of
MCI [51, 52]. The stage of MCI is subdivided into two stages, EMCI and LMCI, as defined
in the ADNI database. Since alleviation of specific symptoms is possible through
therapeutic interventions for some patients in the early or middle stages of AD, effective
diagnosis of EMCI from CN group is essentially important for the planning of early
treatment. However, instead of utilizing PCA computed variances to determine the
significances of different components, the proposed Gaussian discriminative component
analysis (GDCA) makes use of GDA classifiers to reveal the discriminability of different
components in terms of each component’s performance obtained by a designate machine
learning task. The proposed method conducts a dimensionality reduction algorithm taking
into consideration the interclass information to define an optimal eigenspace that
maximizes the discriminability of selected eigenvectors. This process is shown to lead to
stable, reliable and accurate dimensionality reduction in multimodal neuroimaging
biomarkers for effective classification, enhanced diagnosis and the monitoring of disease
progression. The proposed GDCA model has a high potential for deployment as a computer
aided clinical diagnosis system for AD.
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5.2. Materials
The information of the subjects used in this study, the MRI data pre-processing,
and MRI/PET image registration procedure are presented in this section.
5.2.1. Participants and Clinical Data
The data used in conducting this study were collected from the ADNI database
(adni.loni.usc.edu). The ADNI was launched in 2003 as a public-private partnership, led
by Principal Investigator Michael W. Weiner, MD. The primary goal of ADNI has been to
test whether serial MRI, PET, other biological markers, and clinical and
neuropsychological assessment can be combined to predict and gauge the progression of
AD. A total of 906 subjects were considered for this study, which were categorized into
groups of CN (251), EMCI (297), LMCI (196) and AD (162). All individuals underwent
structural MRI and Florbetapir (F18-AV45) PET imaging, where the time gap between the
two imaging modalities was less than 3 months. Details of MRI and AV45 PET data
acquisition can be found on the ADNI website. Summary statistics and participants counts
are listed in Table 17.
Table 17.

Symbol
F/M
Age_PETb
Age_MRIb
Education
MMSEcd
RAVLT_immediatecd

Participant Demographic and Clinical
Information
CN
(n=251)
128/123
75.5 (6.5) a
75.3 (6.6)
16.43 (2.6)
29.04 (1.2)
45.3 (10.6)

EMCI
(n=297)
132/165
71.5 (7.4)
71.3 (7.4)
15.99 (2.7)
28.32 (1.6)
39.5 (10.8)

a

LMCI
(n=196)
85/111
73.8 (8.1)
73.6 (8.0)
16.31 (2.7)
27.61 (1.9)
33.2 (10.8)

AD
(n=162)
68/94
74.9 (7.8)
74.7 (7.8)
15.76 (2.7)
22.77 (2.7)
22.3 (7.0)

Values are represented as mean (standard deviation), except gender (F for
female, M for male), which are frequencies instead
b
Significant group differences (ANOVA for continuous and Chi-square test
for categorical values, significance level is 0.05 by default)
c
Significant group differences (ANCOVA adjusted for Age_PET)
d
Significant differences for all between-group post-hoc tests (Tukey’s HSD
test)
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5.2.2. Image Processing
5.2.2.1. MRI Data Pre-processing
The FreeSurfer (Version 5.3.0) was firstly performed under Linux system
(centos4_x86_64) to transform the original MRI to the standard MNI 305 space, yielding
the image referred to as T1.mgz, which is used as the reference image in the registration
procedure, followed by skull-striping, segmenting, and delineating cortical and subcortical
regions with the corresponding image result termed as aparc+aseg.mgz. Derived from the
images, the following three shape measures were then calculated as morphological features
on each of the 68 FreeSurfer labeled cortical regions for both hemispheres (34 per
hemisphere): 1) cortical thickness, 2) surface area, and 3) cortical volume. Since version
5.3 of FreeSurfer was available, we tested the same data with FreeSurfer 6.0 and found
minimal differences ranging from 1 to 5% and showing no statistical differences in terms
of standardized uptake value ratio measurements (SUVRs).
5.2.2.2. MRI and PET Registration
With 12 degrees of freedom (DOF) onto the postprocessed T1 image, the AV45
PET was linearly registered (using trilinear interpolation), so that the regional amyloid
deposition and gray matter atrophy are compared directly (i.e., thickness for cortical
regions [76-79]), using the FMRIB Software Library (FSL) [80]. Moreover, in order to
gain as much information as possible from PET images, which have relatively low
resolution, the original AV45 PET with skull was utilized in this step. This registration
process introduced in a recent study [81] guaranteed that AV45 PET image had the same
segmentation and parcellation as the MRI image.
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Combined with aparc+aseg.mgz images, the registered AV45 PET was inspected
to obtain the mean standardized uptake values (SUV) for all 68 FreeSurfer labeled cortical
regions. The SUV of the whole cerebellum, including 4 regions of interest (left/right
cerebellum cortex and left/right white matter), was used as the reference region. Finally,
regional SUVs of those 68 cortical regions were normalized by the SUV of the whole
cerebellum to get the cortical-to-cerebellum SUVRs. Accordingly, overall there are 4
different types of neuroimaging features associated with each of the 68 cortical regions,
yielding 272 (4×68) features for each subject in the dataset.
5.3. Methods
After obtaining all needed features derived from raw multimodal neuroimaging
data, as aforementioned, a 272-dimensional feature vector was generated for each subject
in the data set. In this section, the proposed GDCA algorithm is presented for the effective
dimensionality reduction and early diagnosis of AD. The standard PCA is applied to the
original data to find the principal components. Then, the discriminability of each
component is estimated by a one-dimensional GDA classifier, and consequently, all
components are sorted in order of the corresponding classification performance. Finally,
the recursive feature elimination (RFE) is employed to determine the optimal
dimensionality reduction of the Gaussian discriminant components in the classification
outcome. Fig. 13 demonstrates the flowchart of the proposed GDCA model.
5.3.1. Gaussian Discriminative Component Analysis
5.3.1.1. Eigenvectors of the Covariance Matrix
The proposed classification problem can be formulated by having the machine learn
to distinguish between CN (𝑦 = 0), EMCI (𝑦 = 1), LMCI (𝑦 = 2), and AD (𝑦 = 3), based
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Fig. 13. General Flowchart of the Proposed GDCA Algorithm.

on the extracted features 𝑥 ∈ ℝ𝑛 . In order to determine the potential directions of Gaussian
discriminative components of all features, the standard PCA method is carried out. Prior
to running PCA, the data need to be normalized as follows:
53

𝑥=

𝑥−𝜇
𝜎

(11)

where 𝜇 ∈ ℝ𝑛 and 𝜎 ∈ ℝ𝑛 are the mean vector and standard deviation vector of all data,
respectively. This process zeros out the mean of the data, and rescales each feature to have
unit variance, which ensures different features to have the same scale. After normalization,
the covariance matrix Σ can then be computed utilizing the normalized data by the formula
below:
𝑚

1
𝑇
Σ = ∑ 𝑥𝑖 ∙ 𝑥𝑖
𝑚

(12)

𝑖=0

𝑇

where 𝑚 is the total number of data points considered and 𝑥𝑖 is the transpose of the
normalized data point 𝑥𝑖 . Then to project the original data into a k-dimensional subspace
(𝑘 ≤ 𝑛), the eigenvector 𝑢𝑗 ∈ ℝ𝑛 (𝑗 ≤ 𝑘) of the covariance matrix Σ can be computed to
obtain the transformed features 𝑥 ′ ∈ ℝ𝑘 .
5.3.1.2. Supervised Dimensionality Reduction
As indicated earlier, the PCA model sorts the extracted eigenvectors (i.e., the
direction of principal components) based on the variance represented by each eigenvector,
without considering any information from the labels of data as an unsupervised algorithm.
But, in general, only reducing the dimensionality to retain as much as possible of the
variance cannot help in deciding the optimal subspace towards an optimal performance if
a supervised machine learning scenario is contemplated. As a consequence, the proposed
method capitalizes on a supervised dimensionality reduction model making use of a GDAbased classifier. Given the eigenvectors which were computed based on the covariance
matrix Σ given in (12), the GDA model will be trained on each new feature in the
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transformed space to determine the discriminability of each component according to the
corresponding classification performance, subsequently sorting the extracted principal
components in order of their discriminability.
GDA can model 𝑝(𝑥 ′ |𝑦), the distribution of the feature vector 𝑥′ in the transformed
feature space given 𝑦 ∈ {0,1,2,3}, assumed to be distributed according to a Gaussian
distribution, with the generalized density function given in (13):
𝑝(𝑥 ′ ; 𝜇 ′ , Σ ′ ) =

1

1
−1
exp (− (𝑥 ′ − 𝜇 ′ )𝑇 Σ ′ (𝑥 ′ − 𝜇 ′ ))
𝑛
2
√(2𝜋) |Σ|

(13)

where 𝜇′ ∈ ℝ𝑘 is the mean vector in the new transformed feature space, Σ ′ is the new
covariance matrix, |Σ ′ | and Σ ′

−1

denote the determinant and inverse matrix of Σ ′ ,

respectively. To determine the discriminability of each component, since 𝑥 ′ ∈ ℝ1 , the 𝜇′
is the mean of the transformed feature, and Σ ′ is the variance of the transformed feature.
After modelling 𝑝(𝑥 ′ |𝑦), Bayes rule is used to derive the posterior distribution on 𝑦 given
𝑥 ′ as:
𝑝(𝑦|𝑥 ′ ) =

𝑝(𝑥 ′ |𝑦)𝑝(𝑦)
𝑝(𝑥 ′ )

(14)

Here, 𝑝(𝑦) denotes the class prior distribution, which cannot be determined when given a
certain subject, so it is assumed to be absolutely random (for all 𝑎 ≠ 𝑏, 𝑝(𝑦 = 𝑎) = 𝑝(𝑦 =
𝑏)). Furthermore, to make a prediction, it is not necessary to calculate 𝑝(𝑥 ′ ), since
arg max 𝑝(𝑦|𝑥 ′ ) = arg max
𝑦

𝑦

𝑝(𝑥 ′ |𝑦)𝑝(𝑦)
= arg max 𝑝(𝑥 ′ |𝑦)𝑝(𝑦)
𝑦
𝑝(𝑥 ′ )

(15)

Therefore, for classification purposes, the following formula is used instead:
arg max 𝑝(𝑦|𝑥 ′ ) = arg max 𝑝(𝑥 ′ |𝑦)
𝑦

𝑦
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(16)

5.3.1.3. Recursive Component Elimination
The GDA classifier is applied to each component, so that for each eigenvector, the
transformed features can be ranked in terms of classification outcome using cross
validation. In this study, the classification accuracy is used as the key metric to measure
performance, which means the discriminability of each component is determined by its
corresponding classification accuracy expressed as Equation (5) in Chapter III.
Setting the computed accuracies as assigned weights to discriminative components,
the RFE is performed to select the optimal Gaussian discriminative components by
recursively considering smaller and smaller sets of components. First, the entire set of
components were applied to the classifier and estimated by the cross-validation
performance. Then, the least important component is eliminated from current set of
components. That procedure is recursively repeated on the pruned set until the desired set
of Gaussian discriminative components is found with an optimal classification
performance.
5.3.2. Classification Based on GDCA
From the proposed GDCA dimensionality reduction model, the optimal
components are obtained in terms of the classification performance (i.e., the accuracy of
that set of components selected), and would then be applied to other classification
algorithms. Some other metrics are used as well, since, as a clinical application, the
classification performance may not only be evaluated by the accuracy, but could also rely
on precision, recall (or sensitivity) and specificity. The F1 score is also a widely used
measure of performance in statistical analysis of binary classification, by which both
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precision and recall are taken into consideration. The formulas used to calculate these four
metrics are expressed as Equations (6)-(10) in Chapter III.
In order to assess the ability of the obtained transformed feature space in
performance improvement, several widely used classification algorithms are applied on the
original feature space as well as the dimensionality reduced new feature space, including
linear SVM, multilayer perceptron (MLP), and gradient boosting (GB) classifiers. To
demonstrate the advantage of the proposed GDCA over other widely used dimensionality
reduction methods, PCA and univariate feature selection are carried out on the best
performed classifier among the ones mentioned above.
5.4. Experiments and Results
The focus of this study is placed on demonstrating how the proposed dimensionality
reduction model can determine the most discriminative components associated with the
progression of MCI and improve the classification performance. Also, in order to predict
the progression of AD, a multiclass classification was carried out on those three groups of
AD patients (i.e., EMCI, LMCI, AD), therefore, we could further compare the proposed
dimensionality reduction with other widely used methods based on the multiclass
classification performance. Scikit-learn, free software machine learning library, was used
to implement all classification algorithms with cross validation procedure and built-in
experiment pipeline [82]. In the classification experiments, all subjects were randomly split
into training, validation, test sets with 80% of the data used for training, 10% for cross
validation, and 10% for the held-out true test. In order to demonstrate the advantage of the
proposed GDCA method over other dimensionality reduction methods, 5-fold cross
validation was carried out using PCA, univariate feature selection and the proposed GDCA
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Table 18.
The Classification Accuracy of Top-10 Gaussian
Discriminative Components and the Corresponding PCA Rank
CN vs. EMCI
GDCA
Rank
1
2
3
4
5
6
7
8
9
10

Accuracy
65.45%
65.45%
63.64%
63.64%
63.64%
63.64%
63.64%
63.64%
61.82%
61.82%

EMCI vs. LMCI
PCA
Rank
22
186
64
148
207
241
262
267
6
62

GDCA
Rank
1
2
3
4
5
6
7
8
9
10

Accuracy
68.00%
66.00%
66.00%
66.00%
66.00%
64.00%
64.00%
64.00%
62.00%
62.00%

PCA
Rank
204
9
35
105
132
64
170
239
3
74

methods. Finally, a CAD application for detecting different stages of AD was presented
to reveal the potential of this GDCA model to be deployed as a CAD system.
5.4.1. Gaussian Discriminative Components
Given the eigenvectors of the covariance matrix calculated by the whole data, Table
18 shows the classification accuracy of top-10 Gaussian discriminative components based
on the binary classification (i.e., CN vs. EMCI, EMCI vs. LMCI) on the validation data,
and the PCA rank of these components are also provided to demonstrate the difference
between GDCA and PCA. As shown in Table 18, the principal components with higher
variance do not necessarily yield better performance in the classification task than those
with lower variance, which may help in delineating the subtle changes associated with CN
vs. EMCI and with EMCI vs. LMCI.
With the Gaussian discriminative components ranked, the RFE was applied on the
validation data to find the optimal set of components that yielded the best validation
performance in terms of overall classification accuracy. Consequently, these optimal
discriminative components were used to evaluate the proposed GDCA on the held-out test
data. Fig. 14(a) illustrates the CN vs. EMCI learning curves of the training, validation and
testing when increasing the number of Gaussian discriminative components involved in the

58

(a)
(b)
Fig. 14.
The Learning Curves of the Training, Validation and Testing with Different Numbers of
Gaussian Discriminative Components: (a) CN vs. EMCI classification; (b) EMCI vs. LMCI classification.

Table 19.

The Benchmark CN vs. EMCI and EMCI vs. LMCI Classification Performance Based on the
Proposed GDCA Model

Classification
Performance
Cross Validation
Hold-out Test

F1 Score
86.15%
80.70%

CN vs. EMCI
Accuracy Precision
83.64%
80.00%
79.25%
82.14%

Recall
93.33%
79.31%

F1 Score
92.31%
77.78%

EMCI vs. LMCI
Accuracy Precision
94.00%
94.74%
83.33%
82.35%

Recall
90.00%
73.68%

classifier. It can be observed that the proposed model was able to learn the generic
discriminative components through the cross validation and performed similarly on the
held-out test data. Based on the cross validation, the highest accuracy of 79.25% was
obtained by using the first 106 Gaussian discriminative components. The GDCA results
are shown in Table 19, which also sets a performance benchmark for further classification
performance comparison using several different machine learning algorithms. Another
challenging task of detecting different stages in AD is in distinguishing LMCI from EMCI,
because LMCI may have higher risk in developing AD. Thus, EMCI vs. LMCI
classification was carried out following the same procedure, and the results are illustrated
in Table 19 and Fig. 14(b), where the best cross validation performance was attained by
including the first 99 Gaussian discriminative components into the model with an accuracy
of 83.33%.
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Table 20.

Binary Classification Performance Comparison of Original Features and GDCA-transformed
Features

Task

CN vs. EMCI

EMCI vs. LMCI

Feature
Classifier
SVM
MLP
GB
GDA
SVM
MLP
GB
GDA

Original features
F1 Score
72.73%
75.41%
75.41%
66.67%
54.05%
59.46%
48.48%
52.00%

Accuracy
66.04%
71.70%
71.70%
64.15%
64.58%
68.75%
64.58%
50.00%

Precision
64.86%
71.88%
71.88%
67.86%
55.56%
61.11%
57.14%
41.94%

Transformed features
Recall
82.76%
79.31%
79.31%
65.52%
52.63%
57.89%
42.11%
68.42%

F1 Score
78.69%
78.57%
77.19%
80.70%
65.00%
72.73%
60.00%
77.78%

Accuracy
75.47%
77.36%
75.47%
79.25%
70.83%
75.00%
75.00%
83.33%

Precision
75.00%
81.48%
78.57%
82.14%
61.90%
64.00%
81.82%
82.35%

Recall
82.76%
75.86%
75.86%
79.31%
68.42%
84.21%
47.37%
73.68%

5.4.2. Binary Classification Performance Comparison
By applying the relevant classifiers (i.e., SVM, MLP, and GB) to the original data
and to the dimensionality-reduced data, the corresponding results are given in Table 20.
Unlike the proposed GDCA, these algorithms may give us various results due to the
random initialization. The classification experiments were run multiple times, and the
overall best results were reported in Table 20. It can be observed that after introducing the
proposed dimensionality reduction model, all the selected classifiers achieved better
performance on the transformed feature space than obtained on the original features, which
adds credence to the validity of the proposed GDCA model. Moreover, although state-ofthe-art MLP and GB algorithms established better performance than the GDA algorithm
on the original features as a result of the underlying feature selection process, for both CN
vs. EMCI and EMCI vs. LMCI, they did not surpass the benchmark performance yielded
by the proposed GDCA algorithm. However, because of the random initialization,
classification algorithms like SVM, MPL, GB may not always achieve the global optimal
solution, only the GDA classifier is applied here for the multiclass classification
experiment.
As another widely used metric in choosing binary classification models, the
receiver operating characteristic (ROC) curve and the area under the curve (AUC) were
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used to measure the classification performance. The AUC score can reveal the
discriminability of a classification model and to indicate if the false positive and true
positive rates achieved by a model are significantly above random chance. The ROC curves
and the corresponding AUC scores of held-out tests on original and transformed feature
spaces are demonstrated in Fig. 15, and it can be observed that, after carrying out the
proposed GDCA model, the AUC scores improved significantly by 0.15 for CN vs. EMCI
classification and by 0.31 for EMCI vs. LMCI classification. In Table 21, the results
obtained by the proposed GDCA model are compared with those obtained using most
recent state-of-the-art methods based on ADNI data [83-89]. It should be noted that, as

(a)
(b)
Fig. 15.
ROC Curves and AUC Scores on Original Features and GDCA Transformed Features: (a)
CN vs. EMCI classification; (b) EMCI vs. LMCI classification.
Table 21.
Classification
Performance
Pei et al. [83],
2018
Hett et al. [84],
2019
Jie et al. [85],
2018
Jie et al. [86],
2018
Wee et al. [87],
2019
Yang et al. [88],
2019
Kam et al. [89],
2019
Proposed

CN vs. EMCI and EMCI vs. LMCI Classification Performance Comparison with Recent
State-of-the-art Studies Based on ADNI Data
CN vs. EMCI

EMCI vs. LMCI

Subjects
(CN/EMCI/LMCI)

Accuracy

Recall

Specificity

AUC

Accuracy

Recall

Specificity

AUC

-/18/18

-

-

-

-

70.00%

-

-

0.7088

62/65/34

-

-

-

-

70.80%

-

-

0.6240

50/56/43

-

-

-

-

74.80%

-

-

0.7200

50/56/43

78.30%

74.00%

82.10%

0.7710

78.80%

82.10%

74.40%

0.7830

300/314/208

53.00%

60.40%

55.00%

-

63.10%

61.30%

77.60%

-

29/29/18

77.59%

59.09%

-

0.6849

76.60%

66.20%

-

0.7682

48/49/-

76.07%

76.27%

75.87%

-

-

-

-

-

79.25% 79.31%

79.17%

0.7960

83.33%

82.35%

89.66%

0.8947

251/297/196
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shown in Table 21, although most of the studies used relatively small dataset, the proposed
model still achieved overall best performance for both CN vs. EMCI classification and
EMCI vs. LMCI classification; and for the only study having the same number of subjects
[87], the proposed study obtained significantly better performance.
5.4.3. EMCI vs. LMCI vs. AD Multiclass Classification
The same pipeline was followed for the multiclass classification experiments, and
since the F1 score, precision, and recall would no longer be available, the confusion matrix
was used instead to evaluate the performance with each row corresponding to the true class.
The diagonal elements of the confusion matrix represent the number of points for which
the predicted label is equal to the true label, while off-diagonal elements are those that are
misclassified by the classifier. Fig. 16 demonstrates the learning curve of the multiclass
classification experiment using the proposed GDCA, where the best cross validation

Fig. 16.
The Learning Curves of the Training, Validation and Testing with Different Numbers of
Gaussian Discriminative Components for EMCI vs. LMCI vs. AD Classification.
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(a)
(b)
Fig. 17.
EMCI vs. LMCI vs. AD Classification Confusion Matrices: (a) All features were used; (b)
GDCA-transformed features were used.
Table 22.

MCI vs. AD Classification Performance by Converting the EMCI vs. LMCI vs. AD
Classification Results
Features
F1 Score Accuracy Precision Recall
Original
64.52% 83.08% 66.67% 62.50%
Transformed 78.95% 87.69% 68.18% 93.75%

performance was achieved by using the first 90 Gaussian discriminative component. It can
be observed that the learning curve associated with the held-out test is closer to the learning
curve of cross validation in comparison to the learning curve results shown in Fig. 14, since
there were three classes instead of two classes, which enabled the model to learn more
generic discriminative components across all three classes.
Fig. 17 shows the confusion matrices of the held-out test on the original features
and GDCA transformed features. The overall classification accuracy using the transformed
features was 67.69%, compared to 53.85% if all original features were utilized. As shown
in Fig. 17, after applying the proposed GDCA model, the classifier could more precisely
distinguish LMCI and AD from EMCI group, so that the overall classification performance
was improved significantly. Additionally, in Table 22, the multiclass classification results
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are converted to binary classification results of MCI vs. AD, showing that the proposed
method could effectively discriminate AD from MCI with a 31.25% increase on recall.
5.4.4. Dimensionality Reduction Performance Comparison
Since the proposed GDCA method is capable of defining the most discriminative
directions of all eigenvectors, noted improvements were obtained in the classification
results. To demonstrate how this process differs from other widely used dimensionality
reduction methods, 5-fold cross validation was implemented for the EMCI vs. LMCI vs.
AD multiclass classification task by applying the PCA, univariate selection and proposed
GDCA methods. The PCA method, as aforementioned, utilizes PCA computed variances
to determine the significances of the principal components. For univariate selection
method, the eigenvectors of the covariance matrix are not computed, and instead it selects
the best features based on univariate statistical tests. In this study, the ANOVA was
performed as the univariate statistical test to determine the significances of the different
features.
Moreover, rather than adding one feature at a time, the different percentiles were
used to illustrate the classification performance of these dimensionality reduction methods
varying the percentile of features selected. The same GDA classifier was applied to all
these three dimensionality reduction methods so as to eliminate any bias. The 5-fold cross
validation results of these methods are shown in Fig. 18. As demonstrated in Fig. 18, for
the univariate selection method, by selecting one percent of features, it achieved better
performance than PCA and GDCA methods, but when adding more features, it was unable
to improve the performance as significantly as did the PCA and GDCA methods. Overall,
the proposed GDCA method obtained an average accuracy of 63.13% with 20 percent
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dimensions of all features, which is significantly better than the best performance achieved
by the PCA and univariate methods. The difference between these dimensionality

Feature -1

Fig. 18.
EMCI vs. LMCI vs. AD Cross Validation Performance of Different Dimensionality
Reduction Methods Varying the Percentile of Features Selected.

Feature -2
Fig. 19.

A Visualized Example of Different Dimensionality Reduction Methods.
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reduction approaches are also visualized in Fig. 19, in this example, there were two features
associated with two classes, that required to reduce the two-dimensional space to its onedimensional representation. It can be observed that the proposed GDCA approach would
yield the best performance, since it selected the most discriminative component (i.e., GDC1), and in contrast, the PCA method chose the second discriminative component (i.e., PC1) and the univariate method picked the most discriminative feature (i.e., feature-1) from
the original features.
5.4.5. Computer Aided Diagnosis Based on GDCA
The previous sections have indicated that the proposed GDCA model was able to
identify the most discriminative components associated with different stages of AD as a
multiclass classification problem. But, in order to apply the proposed model to a practical
CAD system, the trained model should be able to include the CN group, allowing a given

Fig. 20.
The Learning Curves of the Training, Validation and Testing with Different Numbers of
Gaussian Discriminative Components for the Proposed GDCA-based CAD Application.
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subject in the classification process to belong to any of the 4 groups: CN, EMCI, LMCI
and AD. Therefore, in this section, a multimodal multiclass classification neuroimaging
CAD application involving all four groups (CN, EMCI, LMCI and AD) is presented
utilizing the proposed GDCA model.
The learning curve of the GDCA-based CAD application is shown in Fig. 20, where
the best cross validation performance was obtained by using the first 133 Gaussian
discriminative components. Now, since more interclass information was involved during

(a)
(b)
Fig. 21.
CN vs. EMCI vs. LMCI vs. AD Classification Confusion Matrices: (a) All features were
used; (b) GDCA-transformed features were used.

(a)
(b)
Fig. 22.
CN vs. EMCI vs. LMCI vs. AD 3-dimensional Visualization by Projecting the Data onto the
Affine Subspace: (a) All features were used; (b) GDCA-transformed features were used.
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the training, more generic discriminative components across all four classes were captured,
which resulted in a small gap between the learning curves of the cross validation and the
held-out test. Fig. 21 demonstrates the confusion matrices of the held-out true test on the
original features and GDCA transformed features. As the most complicated task in AD
classification, the accuracy of 53.93% was attained, which reached only 41.57% when all
original features were used. Making use of GDA, Fig. 22 illustrates the 3-dimensional
visualization by projecting the high dimensional data onto the affine subspace generated
by the estimated class means of all classes. In Fig. 21 and Fig. 22, it can be observed that,
after applying the proposed GDCA model, the classifier could detect the subtle difference
between MCI group (i.e., EMCI and LMCI) and CN group as well as MCI group and AD
group more effectively, in particular, more CN and AD subjects were correctly detected.
Furthermore, in order to illustrate the performance improvement of the GDCAbased CAD application, some extension of ROC to multiclass classification were carried
out, including, one-against-rest ROC curve for each class, micro-averaging and macroaveraging ROC curves. Micro-averaging considers each element of the label indicator
matrix as a binary prediction, while macro-averaging gives equal weight to the

(a)
(b)
Fig. 23.
ROC Curves to Multiclass Classification and AUC Scores for the Proposed GDCA-based
CAD Application: (a) All features were used; (b) GDCA-transformed features were used.
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classification of each label. The ROC curves and the corresponding AUC scores are
demonstrated in Fig. 23, and it can be observed that, after carrying out the proposed GDCA
model, the micro-averaging and macro-averaging AUC scores were increased significantly
by 9.71% and 8.73%, respectively. For AD vs. rest and CN vs. rest, the performances were
also improved significantly, and AUC scores of 0.7919 and 0.9092, respectively were
achieved.
As shown in Fig. 22, after applying the GDCA model, the classification
improvement was attributed to more of the CN and AD subjects correctly distinguished
from EMCI and LMCI groups. Therefore, in order to demonstrate the performance
improvement on CN vs. MCI vs. AD classification, the CAD results of EMCI and LMCI
were combined together as MCI. By combining those results, the confusion matrices on
the original features and GDCA transformed features are shown in Fig. 24.

After

combining, the overall classification accuracy on original and transformed features was
57.30% and 66.29%, respectively. And more notably, if the MCI and AD results were

(a)
(b)
Fig. 24.
CN vs. MCI vs. AD Classification Confusion Matrices by Combining EMCI and LMCI: (a)
All features were used; (b) GDCA-transformed features were used.
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further combined as diseased group, it indicates that the proposed GDCA-based CAD
application can effectively discriminate diseased subjects from the CN group with an
accuracy of 75.28%, an F1 score of 82.51%, a precision of 83.87%, and a recall of 81.25%.
These results show that the proposed GDCA model has a high potential for use as a clinical
CAD system using multimodal neuroimaging data.
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CHAPTER VI.
MILD

COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT IN

COGNITIVE

IMPAIRMENT

BASED

ON

NATURAL

LANGUAGE

PROCESSING -ORIENTED FEATURE EXTRACTION
6.1. Goal
Typically, neuropsychological testing helps medical experts situate a given patient
in continuum of the AD spectrum, especially in the continuum between CN and the
prodromal stage of MCI. This chapter focuses on developing an NLP-oriented
computerized neuropsychological assessment taking advantage of the existing NLP
techniques to find significant patterns of changes in linguistic complexity associated with
the progression of AD. By applying NLP techniques, it is possible to precisely diagnose
MCI based on the analysis of some conversation contents, such as, spoken features, lexical
features and syntactic features [62]. Some case studies have indicated that the NLP technic
is able to find clear patterns of decline in syntactic and grammatical complexity [60, 61].
The proposed system will extract key features from discourse transcripts, and evaluate on
non-scripted news conferences from President Ronald Reagan (RR), who was diagnosed
with Alzheimer’s disease in 1994, and some other presidents, who have no known
diagnosis of AD, then indicate that over time, the patterns of the linguistic complexity
changes are significantly distinguishable between RR and CN people.
6.2. Methodology
The innovative work for the proposed study is the development of a computerized
neuropsychological test taking advantage of advances in state-of-the-art NLP technologies,
so the test can automatically extract key features and discover the significant linguistic
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Fig. 25.

General Framework of the Proposed Computerized Assessment.

changes associated with MCI. The general framework of the proposed NLP-oriented
computerized neuropsychological assessment system is shown in Fig. 25.
6.2.1. Subjects
As one of the most well-known AD patients, RR was diagnosed with AD in 1994,
six years after he left office; however, speculation of his cognitive decline while in office
has been the subject of both academic scholarship and popular debate. Since RR’s
presidency was 6 years before his diagnosis of AD, he may have been at the MCI stage
during his term(s) of office. The availability of official archives of presidential transcripts
offers an opportunity to address questions regarding linguistic changes over time for MCI
[90]. And for the control group, this study chooses President Dwight D. Eisenhower (DE),
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and President George H. W. Bush (GB), who have no known diagnosis of AD, to avoid the
influence for the linguistic changes caused by the age, where all three presidents were over
60 years old (RR was 69, DE was 62, and GB was 64 at the beginning of their presidency,
respectively), that onset of AD first affects people in their mid-60s in most cases.
Using 46 transcripts of RR’s press conferences (1981–1988), the extracted
linguistic features would show change longitudinally with MCI. For maintaining
equivalence of the data size, 46 transcripts of the press conferences of DE (1953–1961),
and GB (1989–1993) were randomly selected for comparing trends in linguistic changes
against those of RR. The data of the news conference transcripts were obtained from the
American Presidency Project archive as a data source for this project [90]. The project is a
comprehensive and organized searchable database of presidential documents, including
transcripts of speeches, transcripts of news conferences, and other public documents. It
ought to be noted that for the linguistic analysis in this study, the 46 transcripts of every
president were grouped into 9 subsets in order of the date when they were made. In order
to maintain the same number of transcripts and ensure enough document size in one subset,
each subset included five consecutive transcripts, except the last one which contains the
final six transcripts.
6.2.2. Pre-processing
There are typically two parts of Presidential press conferences: 1) a prepared
statement or announcement read by the president and 2) a spontaneous question/answer
session where the president can take questions from members of the media. It is often the
case that the prepared statements are at least partially written by presidential speechwriters
or staff members. As a result, for our analysis the focus was placed only on the latter since
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the non-scripted nature of the discourse is cognitively more sensitive for our linguistic
analysis.
6.2.2.1. Filtering
To generate the corpus for analysis, a transcript was downloaded, and then the
prepared statement or announcement by the president and all discourses by other
individuals (e.g., questions, statements and answers) were omitted. All annotations in
brackets need to be filtered that refer to addendums to the transcripts by the editors to
provide context (e.g., <Laughter>, Walt <Walter Rodgers, Associated Press Radio>, etc.).
6.2.2.2. Tokenization
Using the Natural Language Processing Tool Kit in Python (NLTK) [91], sentence
tokenization and word tokenization were performed for each transcript. Tokenization is the
process of splitting a stream of text into some smaller meaningful elements. After the
sentence tokenization, every single sentence was derived from the original transcriptions.
Then, implementing the word tokenization, each sentence would be broken up into words
for further feature extraction processing.
6.2.3. Lexical Analysis
The first set of features extracted from the news conference transcripts was based
on the lexical analysis, which generated 7 features corresponding to three types of words:
1) unique words, 2) non-specific words, and 3) specific words.
6.2.3.1. Unique Words
In order to obtain all the unique words in each transcript, each word was reduced
to their stem, base, or root form. For example, the words item, items and itemization share
a common root form, item, therefore, they were treated as the same unique word. The
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stemming process was automatically implemented by using the Snowball Stemmer in
NLTK [91], then the number of unique word was the first feature extracted from the
transcripts. The number of unique words should remain the same for CN people, but for
MCI patients, who have started forgetting some frequently used words, as a result, that
number should decrease over the progression of MCI.
6.2.3.2. Non-specific Words
According to the aforementioned unique words, for each subset of transcripts, those
words appearing in every transcript were considered as non-specific (NS) words, which
means they are not that specific for each transcript but just depend on the word-using habit
of a person. NS words should remain the same amount for CN people, but when some
memory decline occurs due to MCI, the patients may have some difficulties to find
different words to describe the similar thing or situation, i.e., the diversity of their discourse
would also decline in the change of the use of NS terms. Therefore, the number of NS
words, the frequency of NS words (i.e., the number of NS words/the number of unique
words), and the rate of NS words (i.e., the total count of NS words/the number of NS words)
are the three features related to NS words.
6.2.3.3. Specific Words
Unlike the NS words, specific (SPE) words are those words which are more
meaningful and interesting for a given conversation. In this study, for a subset of
transcripts, those words exactly appeared in only one transcript were regarded as being
specific to that transcript. For CN people, SPE words should remain the same amount, but
for MCI, the memory problem should cause a decrease of the usage of SPE terms. Then,
there were three features related to SPE words, the number of SPE words, the frequency of
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Fig. 26.

The Parsing Tree of the Sentence ‘My dog also likes eating sausage.’

SPE words (i.e., the number of SPE words/the number of unique words), and the rate of
SPE words (i.e., the total count of SPE words/the number of SPE words).
6.2.4. Grammatical Analysis
The second set of features extracted from the news conference transcripts took
advantage of the grammatical analysis. The Stanford English PCFG parser was used to
calculate the grammatical complexity of the transcripts [92]. For each sentence obtained
from the sentence tokenization, the parser can produce a hierarchical tree representation of
a given sentence as shown in Fig. 26. For the given sentence in Fig. 26, ‘My dog also likes
eating sausage.’, three measures were introduced, the depth of the parsing tree, the width
of the parsing tree, and the ratio of the depth to the width, in this example, which are 6, 7
and 0.86 (i.e., 6/7), respectively. Then, for each subset of the transcripts, the average of the
three measures of all the sentence were used as the features of the grammatical complexity,
which should be expected to indicate different patterns between CN and MCI.
6.2.5. Linear Regression Analysis
For each of the 10 linguistic features, a linear regression analysis based on the
Pearson correlation coefficient (PCC) was carried out to evaluate statistically significant
changes in these variables over time for RR, DE, and GB. PCC is a measure of the linear
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correlation between two variables. It has a value between +1 and −1, where 1 is total
positive linear correlation, 0 is no linear correlation, and −1 is total negative linear
correlation. For each obtained PPC, the linear regression analysis also computes the
corresponding p-value, so that the statistical significance could be evaluated as well.

(a)

(b)

(c)
Fig. 27.

The Trend of 3 Lexical Analysis Counting Features.
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Fig. 28.

(a)

(b)

(c)

(d)

The trend of 4 Lexical Analysis Ratio Features.

6.3. Results
In this section, results of the proposed computerized assessment reveal significant
different trend of linguistic complexity changes between MCI subject (i.e., RR) and CN
subjects (i.e., DE and GB). The PCCs and statistical significances of all 10 features of each
president are presented.
6.3.1. Linguistic Complexity Changes
Fig. 27, Fig. 28 and Fig. 29 demonstrate the expected patterns of linguistic
complexity changes over time. As shown in Fig. 27(a), (b), (c) for RR, the number of
unique words, NS words, and SPE words, indicate a significant decreasing trend during his
presidency, but the values of the same features for DE and GB slightly increased or
remained at the same level over time. The same pattern can be observed in Fig. 28(a) for
the frequency of NS words. From Fig. 28(b), the decline of the frequency of SPE words is
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(a)

(b)

(c)
Fig. 29.

The Trend of 3 Grammatical Analysis Features.

apparent for GB and DE, whereas the frequency of SPE words of RR indicates no change
trend over time. For the grammatical complexity changes, there are no pattern found to be
significantly distinguishable between RR and others as shown in Fig. 29.
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6.3.2. Pearson Correlation Coefficient
The linear regression analysis supports the observations made in Fig. 27, Fig. 28,
Fig. 29, and in Table 23. For RR, the number of unique words, NS words, and SPE words,
and the frequency of NS words all decreased at 0.95 level of significance (LOS), but for
DE and GB, these features all fairly increased or remained the same. Moreover, the
frequency of SPE words for RR almost stayed at the same level with the PCC of -0.075,
but for DE and GB, this feature indicated a significant reduction at 0.90 LOS with the PCC
of -0.626 and -0.724, respectively. It ought to be noted that since GB held one term of
office while both RR and DE completed two terms, some statistical values of GB may not
reflect the real pattern associated with CN as compared to those obtained from DE. From
Fig. 27, Fig. 28, Fig. 29, and Table 23, it can be observed that except for the rate of NS
words, all other features delineate the opposite trend of linguistic complexity changes
between RR and DE.
Table 23.

Linear Regression Analysis of 10 Features
RR

President
Number of
Unique words
Number of NS
words
Number of
SPE words
Frequency of
NS words
Frequency of
SPE words
Rate of NS
words
Rate of SPE
words
Depth of
parsing trees
Width of
parsing trees
Ratio of depth
to width

Coeff.

p-value

DE
Coeff.

p-value

GB
Coeff.

p-value

-0.766

0.016

0.711

0.032

0.518

0.153

-0.880

0.002

0.164

0.673

0.188

0.629

-0.856

0.003

0.537

0.136

-0.007

0.985

-0.876

0.002

-0.159

0.683

0.057

0.884

-0.075

0.848

-0.626

0.071

-0.724

0.027

0.886

0.001

0.452

0.222

0.640

0.063

0.054

0.891

-0.679

0.044

0.447

0.228

-0.106

0.787

0.818

0.007

-0.184

0.635

-0.752

0.019

0.797

0.010

-0.606

0.083

0.819

0.007

-0.746

0.021

0.622

0.074

RR: Ronald Reagan, DE: Dwight D. Eisenhower, GB: George H. W.
Bush, NS: non-specific, SPE: specific, Coeff.: coefficient
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CHAPTER VII. COCLUSION
In Chapter II, the dissertation showed that, by using only structural MRI data, the
proposed GDA-based generative learning algorithm achieved an accuracy of 85.90%,
sensitivity of 83.87%, specificity of 87.23%, positive predictive value of 81.25%, and
negative predictive value of 89.13% for discriminating AD from CN; these results for these
two groups were expected. But more importantly, an accuracy of 82.20%, sensitivity of
83.10%, specificity of 80.85%, positive predictive value of 86.76%, and negative
predictive value of 76.00% were obtained for discriminating MCI from CN that are very
competitive. The proposed GDA-based classifier is capable of solving nonlinear
boundaries for discriminating AD and MCI from CN in consideration of correlations
among all variables. And most importantly, by separating left and right hemispheres of the
brain into two decision spaces, and then combining results of these two spaces to determine
the final outcomes, the classification performance is improved significantly.
Chapter III proposed GDA-based dual high-dimensional decision spaces for the
diagnosis of MCI in AD using structural MRI data as the unique input. The feature selection
in this study demonstrates that the entorhinal cortex is the most significant cortical region
for distinguishing CN from MCI and more evidently for AD, which is consistent with
recent studies that concluded that the entorhinal cortex, deep in the brain, is the first area
to be implicated in AD. As a clinical application, when selecting the optimal sets of
variables, the classification performance is measured by the F1 score instead of the
accuracy in consideration of the imbalanced data. Another major contribution of this study
is that by performing the feature selection and training process to both left and right
hemispheres of the brain separately, then generating dual decision spaces instead of
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typically using only one decision space, the classification performance is shown to improve
significantly.
In Chapter IV, this dissertation presented a novel classification algorithm with
global feature selection using structural MRI data as the unique input for the CAD in AD
classification. The noise detection process was able to remove all abnormal subject
datasets. Then based on ANOVA, the global feature ranking procedure sorted all features
depending on their statistical significance associated with the progression of AD, then the
IEA obtained the optimal set of global features taking advantage of the F1 score instead of
the accuracy in consideration of the imbalanced data. The GDA-based classifier was
effectively and accurately trained to discriminate different stages of AD using the
innovative two high-dimensional decision spaces reflecting the left and right hemispheres.
Furthermore, with the strategic two-phase classification process, the presented method
achieved perhaps one of the best classification performance in delineating the most
challenging groups of MCI and CN with an unprecedented accuracy of 88.78%, a
sensitivity of 91.08%, and a specificity of 83.78%.
In Chapter V, a novel GDCA dimensionality reduction algorithm was proposed to
characterize the optimal Gaussian discriminative components of the original high
dimensional feature space, maximizing as a consequence the discriminability of selected
eigenvectors. The CN vs. EMCI classification results indicated that the proposed
supervised method was able to delineate the subtlest changes associated with the EMCI
group. After transforming the original features to the optimal Gaussian discriminative
components, a high accuracy of 79.25%, an F1 score of 80.70% and an AUC score of
0.7960 were obtained, which showed high potential of the proposed method for clinical
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diagnosis of the early stage of AD. For EMCI vs. LMCI classification, the proposed model
achieved a high accuracy of 83.33%, an F1 score of 77.78%, and an AUC score of 0.8947.
These results of CN vs. EMCI classification and EMCI vs. LMCI classification are
considered as the best classification performance obtained so far.
Chapter V also carried out a multiclass classification was also for the detection of
the different stages in AD (i.e., EMCI, LMCI, and AD). An overall accuracy of 67.69%
was achieved, and moreover, the proposed method was able to distinguish AD from MCI
with an accuracy of 87.69% and a recall of 93.75%, respectively. The comparison with
other widely used dimensionality reduction methods indicated that the proposed method
could significantly reduce the dimensionality of the data and still accomplish an effective
classification performance. A CAD application based on the proposed GDCA model was
also presented, which attained an overall accuracy of 66.29% for CN vs. MCI vs. AD
classification, and more notably, for distinguishing diseased subjects (i.e., MCI and AD)
from CN group, with an accuracy of 75.28%. The future work will ultimately focus on
taking advantage of the proposed GDCA algorithm to build a CAD system that could help
in delineating the EMCI group in a multiclass classification process that could be helpful
in the planning of early treatment and therapeutic interventions.
In Chapter VI, the dissertation indicated that, even though President Reagan was
not diagnosed with AD until August of 1994, the results of the proposed computerized
assessment suggest that changes in linguistic complexity were becoming detectable years
prior to clinical diagnosis. In the news conferences of RR, the significant decline was found
for the average length of sentences and the use of unique words, NS words and SPE words.
An increasing trend of the ratio of depth to width of the sentences’ parsing trees over time
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was significant during President Reagan’s presidency. Analysis of his transcripts revealed
significant differences in variables known to be associated with the onset of MCI. To
address the potential confound associated with changes resulting from healthy aging, by
comparing RR’s transcripts to those of DE and GB. At the start of their presidencies, DE
was 62, RR was 69 years old, and GB was 64 (the year 1953, 1981 and 1989 respectively).
Although the three age spans differ slightly, DE and GB provide the most comparable cases
among the modern American presidents. Furthermore, the results are consistent with an
early study indicating that RR’s presidential debates contained the detectable patterns of
AD as early as 1980 [93]. Instead of typically using simple statistic and fixed feature sets,
by applying the state-of-the-art NLP technologies, this study indicated the significantly
different patterns of the linguistic complexity changes between CN and MCI subjects,
which can be applied to the diagnosis of MCI.
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